<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy - Riley, P - 2015 | Cochrane Library</title> <meta content="Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy - Riley, P - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011552.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy - Riley, P - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011552.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011552.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy" name="citation_title"/> <meta content="Philip Riley" name="citation_author"/> <meta content="School of Dentistry, The University of Manchester" name="citation_author_institution"/> <meta content="philip.riley@manchester.ac.uk" name="citation_author_email"/> <meta content="Anne‐Marie Glenny" name="citation_author"/> <meta content="School of Dentistry, The University of Manchester" name="citation_author_institution"/> <meta content="Helen V Worthington" name="citation_author"/> <meta content="School of Dentistry, The University of Manchester" name="citation_author_institution"/> <meta content="Anne Littlewood" name="citation_author"/> <meta content="School of Dentistry, The University of Manchester" name="citation_author_institution"/> <meta content="Jan E Clarkson" name="citation_author"/> <meta content="University of Dundee" name="citation_author_institution"/> <meta content="Martin G McCabe" name="citation_author"/> <meta content="The University of Manchester" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD011552.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/12/23" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011552.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011552.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011552.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Antineoplastic Agents [administration &amp; dosage, adverse effects]; Cryotherapy [*methods]; Fluorouracil [administration &amp; dosage, adverse effects]; Hematopoietic Stem Cell Transplantation; Melphalan [administration &amp; dosage, adverse effects]; Mouth Diseases [etiology, therapy]; Myeloablative Agonists [administration &amp; dosage, adverse effects]; Neoplasms [*therapy]; Pain [etiology]; Randomized Controlled Trials as Topic; Stomatitis [chemically induced, *prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011552.pub2&amp;doi=10.1002/14651858.CD011552.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="urvLIhM4";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011552\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011552\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011552\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011552\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ms","hr","th","fa","hi"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011552.pub2",title:"Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy",firstPublishedDate:"Dec 23, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Oral Health Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=urvLIhM4&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011552.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011552.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011552.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011552.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011552.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011552.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;hi&quot;,&quot;title&quot;:&quot;सारांश&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hi&quot;,&quot;title&quot;:&quot;सरल भाषा संक्षेप&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011552.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011552.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011552.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011552.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>17919 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011552.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/full#CD011552-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/full#CD011552-sec-0161"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/full#CD011552-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/full#CD011552-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/full#CD011552-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/full#CD011552-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/full#CD011552-sec-0060"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/full#CD011552-sec-0153"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/appendices#CD011552-sec-0166"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/table_n/CD011552StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/table_n/CD011552StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/information#CD011552-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Philip Riley</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/information#CD011552-cr-0003">Anne‐Marie Glenny</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/information#CD011552-cr-0004">Helen V Worthington</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/information#CD011552-cr-0005">Anne Littlewood</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/information#CD011552-cr-0006">Jan E Clarkson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011552.pub2/information#CD011552-cr-0007">Martin G McCabe</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/information/en#CD011552-sec-0177">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 23 December 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011552.pub2">https://doi.org/10.1002/14651858.CD011552.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011552-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011552-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011552-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011552-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hi#CD011552-abs-0012">हिंदी</a> </li> <li class="section-language"> <a class="" href="full/th#CD011552-abs-0006">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011552-abs-0001" lang="en"> <section id="CD011552-sec-0001"> <h3 class="title" id="CD011552-sec-0001">Background</h3> <p>Oral mucositis is a side effect of chemotherapy, head and neck radiotherapy, and targeted therapy, affecting over 75% of high risk patients. Ulceration can lead to severe pain and difficulty eating and drinking, which may necessitate opioid analgesics, hospitalisation and nasogastric or intravenous nutrition. These complications may lead to interruptions or alterations to cancer therapy, which may reduce survival. There is also a risk of death from sepsis if pathogens enter the ulcers of immunocompromised patients. Ulcerative oral mucositis can be costly to healthcare systems, yet there are few preventive interventions proven to be beneficial. Oral cryotherapy is a low‐cost, simple intervention which is unlikely to cause side‐effects. It has shown promise in clinical trials and warrants an up‐to‐date Cochrane review to assess and summarise the international evidence. </p> </section> <section id="CD011552-sec-0002"> <h3 class="title" id="CD011552-sec-0002">Objectives</h3> <p>To assess the effects of oral cryotherapy for preventing oral mucositis in patients with cancer who are receiving treatment. </p> </section> <section id="CD011552-sec-0003"> <h3 class="title" id="CD011552-sec-0003">Search methods</h3> <p>We searched the following databases: the Cochrane Oral Health Group Trials Register (to 17 June 2015), the Cochrane Central Register of Controlled Trials (CENTRAL) (<i>Cochrane Library</i> 2015, Issue 5), MEDLINE via Ovid (1946 to 17 June 2015), EMBASE via Ovid (1980 to 17 June 2015), CANCERLIT via PubMed (1950 to 17 June 2015) and CINAHL via EBSCO (1937 to 17 June 2015). We searched the US National Institutes of Health Trials Registry, and the WHO Clinical Trials Registry Platform for ongoing trials. No restrictions were placed on the language or date of publication when searching databases. </p> </section> <section id="CD011552-sec-0004"> <h3 class="title" id="CD011552-sec-0004">Selection criteria</h3> <p>We included parallel‐design randomised controlled trials (RCTs) assessing the effects of oral cryotherapy in patients with cancer receiving treatment. We used outcomes from a published core outcome set registered on the COMET website. </p> </section> <section id="CD011552-sec-0005"> <h3 class="title" id="CD011552-sec-0005">Data collection and analysis</h3> <p>Two review authors independently screened the results of electronic searches, extracted data and assessed risk of bias. We contacted study authors for information where feasible. For dichotomous outcomes, we reported risk ratios (RR) and 95% confidence intervals (CI). For continuous outcomes, we reported mean differences (MD) and 95% CIs. We pooled similar studies in random‐effects meta‐analyses. We reported adverse effects in a narrative format. </p> </section> <section id="CD011552-sec-0006"> <h3 class="title" id="CD011552-sec-0006">Main results</h3> <p>We included 14 RCTs analysing 1280 participants. The vast majority of participants did not receive radiotherapy to the head and neck, so this review primarily assesses prevention of chemotherapy‐induced oral mucositis. All studies were at high risk of bias. The following results are for the main comparison: oral cryotherapy versus control (standard care or no treatment). </p> <p><b>Adults receiving fluorouracil‐based (5FU) chemotherapy for solid cancers</b> </p> <p>Oral cryotherapy probably reduces oral mucositis of any severity (RR 0.61, 95% CI 0.52 to 0.72, 5 studies, 444 analysed, moderate quality evidence). In a population where 728 per 1000 would develop oral mucositis, oral cryotherapy would reduce this to 444 (95% CI 379 to 524). The number needed to treat to benefit one additional person (NNTB), i.e. to prevent them from developing oral mucositis, is 4 people (95% CI 3 to 5). </p> <p>The results were similar for moderate to severe oral mucositis (RR 0.52, 95% CI 0.41 to 0.65, 5 studies, 444 analysed, moderate quality evidence). NNTB 4 (95% CI 4 to 6). </p> <p>Severe oral mucositis is probably reduced (RR 0.40, 95% CI 0.27 to 0.61, 5 studies, 444 analysed, moderate quality evidence). Where 300 per 1000 would develop severe oral mucositis, oral cryotherapy would reduce this to 120 (95% CI 81 to 183), NNTB 6 (95% CI 5 to 9). </p> <p><b>Adults receiving high‐dose melphalan‐based chemotherapy before haematopoietic stem cell transplantation (HSCT)</b> </p> <p>Oral cryotherapy may reduce oral mucositis of any severity (RR 0.59, 95% CI 0.35 to 1.01, 5 studies, 270 analysed, low quality evidence). Where 824 per 1000 would develop oral mucositis, oral cryotherapy would reduce this to 486 (95% CI reduced to 289 to increased to 833). The NNTB is 3, although the uncertainty surrounding the effect estimate means that the 95% CI ranges from 2 NNTB, to 111 NNTH (number needed to treat in order to harm one additional person, i.e. for one additional person to develop oral mucositis). </p> <p>The results were similar for moderate to severe oral mucositis (RR 0.43, 95% CI 0.17 to 1.09, 5 studies, 270 analysed, low quality evidence). NNTB 3 (95% CI 2 NNTB to 17 NNTH). </p> <p>Severe oral mucositis is probably reduced (RR 0.38, 95% CI 0.20 to 0.72, 5 studies, 270 analysed, moderate quality evidence). Where 427 per 1000 would develop severe oral mucositis, oral cryotherapy would reduce this to 162 (95% CI 85 to 308), NNTB 4 (95% CI 3 to 9). </p> <p>Oral cryotherapy was shown to be safe, with very low rates of minor adverse effects, such as headaches, chills, numbness/taste disturbance, and tooth pain. This appears to contribute to the high rates of compliance seen in the included studies. </p> <p>There was limited or no evidence on the secondary outcomes of this review, or on patients undergoing other chemotherapies, radiotherapy, targeted therapy, or on comparisons of oral cryotherapy with other interventions or different oral cryotherapy regimens. Therefore no further robust conclusions can be made. There was also no evidence on the effects of oral cryotherapy in children undergoing cancer treatment. </p> </section> <section id="CD011552-sec-0007"> <h3 class="title" id="CD011552-sec-0007">Authors' conclusions</h3> <p>We are confident that oral cryotherapy leads to large reductions in oral mucositis of all severities in adults receiving 5FU for solid cancers. We are less confident in the ability of oral cryotherapy to reduce oral mucositis in adults receiving high‐dose melphalan before HSCT. Evidence suggests that it does reduce oral mucositis in these adults, but we are less certain about the size of the reduction, which could be large or small. However, we are confident that there is an appreciable reduction in severe oral mucositis in these adults. </p> <p>This Cochrane review includes some very recent and currently unpublished data, and strengthens international guideline statements for adults receiving the above cancer treatments. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011552-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011552-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011552-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011552-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011552-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hi#CD011552-abs-0013">हिंदी</a> </li> <li class="section-language"> <a class="" href="full/hr#CD011552-abs-0005">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011552-abs-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/th#CD011552-abs-0007">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011552-abs-0002" lang="en"> <h3>Can keeping the mouth cold during cancer treatment help to prevent mouth soreness and ulcers in children and adults? </h3> <p><b>Review question</b> </p> <p>This review has been produced to assess whether or not keeping the mouth cold during cancer treatment, by using ice, ice‐cold water, ice cream or ice lollies/popsicles, can help prevent mouth soreness and ulcers in children and adults. </p> <p><b>Background</b> </p> <p>People receiving treatment for cancer are at risk of developing a sore mouth and ulcers as a side effect. This side effect is called oral mucositis and affects over 75% of high‐risk patients (those receiving radiotherapy to the head and neck or high‐dose chemotherapy). The pain caused by this condition can be severe and can stop the person's ability to eat and drink, which may mean they need to take strong pain killers, stay in hospital and be fed through a tube into their stomach, or even into their veins. This in turn can lead to disruption to their cancer treatment, meaning they are not receiving the best possible treatment. The results may be a reduction in the patient's chances of survival, and increased costs to the healthcare system. Cancer patients have weakened immune systems due to their treatment, meaning that their bodies are less able to fight infections. This can be a problem if bacteria enter the body through the ulcer, which is an open wound. This can lead to sepsis (a dangerous inflammatory reaction of the body to infection), which requires antibiotics and hospitalisation, and can cause death. </p> <p>Oral cryotherapy is the cooling of the mouth using ice, ice‐cold water, ice cream or ice lollies/popsicles. It is thought to help prevent oral mucositis in people receiving certain types of chemotherapy because the coldness makes the blood vessels in the mouth more narrow, and this reduces the amount of blood containing chemotherapy drugs from reaching the mouth and causing oral mucositis. It is a low‐cost, natural treatment without serious side effects. </p> <p><b>Study characteristics</b> </p> <p>Authors from the Cochrane Oral Health Group carried out this review of existing studies and the evidence is current up to 17 June 2015. It includes 14 studies published from 1991 to 2015 in which 1316 participants were randomised (1280 of whom were included in the analyses) to receive oral cryotherapy versus standard care (usually saline mouthrinses) or no treatment or a different treatment or a different method of oral cryotherapy, and the number of people developing oral mucositis of different severities was compared. Nearly all the evidence was on adults receiving oral cryotherapy versus standard care or no treatment. This evidence fell into two main groups: 1) adults receiving fluorouracil‐based (5FU) treatment for solid cancers; or 2) adults receiving high‐dose melphalan‐based cancer treatment before haematopoietic stem cell transplantation (HSCT). HSCT is given to help the body to produce all types of blood cells, which are destroyed during cancer treatment. </p> <p><b>Key results</b> </p> <p>There is evidence showing that oral cryotherapy can lead to large reductions in the numbers of adults who get oral mucositis of all severities after receiving 5FU‐based treatment for solid cancers. There is less certain evidence to suggest that oral cryotherapy may reduce the numbers of adults who get oral mucositis after receiving high‐dose melphalan‐based cancer treatment prior to HSCT. The evidence suggests that it does reduce oral mucositis in these adults, but the size of the reduction is much less certain. However, there is more certain evidence that there is a large reduction in severe oral mucositis in these adults. </p> <p>Oral cryotherapy did not cause any serious side effects in any of the participants of these studies, and most people seemed able to carry it out properly and complete it. </p> <p><b>Quality of the evidence</b> </p> <p>The evidence presented, on the main outcome of whether or not people developed oral mucositis of all severities, is of moderate (because the nature of the oral cryotherapy treatment meant that the studies could not be 'blinded' which is a desirable characteristic of these studies) to low quality (because in addition to the above problem, the results of the individual studies were too different to give a precise result when they were combined). </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011552-sec-0161" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011552-sec-0161"></div> <h3 class="title" id="CD011552-sec-0162">Implications for practice</h3> <section id="CD011552-sec-0162"> <p>We are confident that oral cryotherapy leads to large reductions in the incidence of oral mucositis of all severities in adults receiving fluorouracil‐based (5FU) treatment for solid cancers. We are less confident in the ability of oral cryotherapy to reduce the incidence of oral mucositis in adults receiving high‐dose melphalan‐based cancer treatment prior to haematopoietic stem cell transplantation (HSCT). Evidence suggests that it does reduce oral mucositis in these adults, but we are less certain about the size of the reduction, which could be large or small. However, we are confident that there is an appreciable reduction in severe oral mucositis in these adults. </p> <p>This Cochrane systematic review has included some very recent and currently unpublished data, and strengthens international guideline statements for adults receiving the above cancer treatments. </p> </section> <h3 class="title" id="CD011552-sec-0163">Implications for research</h3> <section id="CD011552-sec-0163"> <p>It is fairly clear that oral cryotherapy is beneficial for adults receiving 5FU chemotherapy, and therefore further randomised controlled trials (RCTs) are probably not warranted. Instead, it may be better to conduct new head‐to‐head RCTs comparing oral cryotherapy with other promising preventive treatments such as lasers, growth factors and cytokines, and other interventions. </p> <p>We need more studies assessing oral cryotherapy in people receiving high‐dose melphalan‐based cancer treatment prior to HSCT in order to further strengthen the body of evidence reported in this review. Further investigation of the optimum cryotherapy regimen may be warranted in these patients and, as mentioned above, more head‐to‐head studies. We also need more studies looking at the effects of oral cryotherapy in people receiving other cancer treatments, such as different chemotherapy drugs (including those given as prophylaxis for graft‐versus‐host disease after HSCT), radiotherapy, and even targeted therapies. Studies of children may also be warranted if this intervention can help them complete their optimum cancer treatment regimens, whilst minimising their pain, discomfort and ability to eat and drink properly. </p> <p>We urge trialists conducting future RCTs to measure and report all the outcomes, as a minimum, listed in the core outcome set produced by Bellm et al (<a href="./references#CD011552-bbs2-0034" title="BellmLA , CunninghamG , DurnellL , EilersJ , EpsteinJB , FlemingT , et al. Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board. Cancer Investigation2002;20(5‐6):793‐800. ">Bellm 2002</a>). For our primary outcome of oral mucositis, it would be beneficial to use both a measurement tool such as the WHO or NCI‐NCT scale (<a href="./appendices#CD011552-sec-0174">Appendix 8</a>), to allow us to combine the data with those already included in this review, and also an objective scale with blinded outcome assessment, in order to reduce the bias inherent in these studies. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011552-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011552-sec-0029"></div> <div class="table" id="CD011552-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Cryotherapy versus control for preventing oral mucositis in adults receiving fluorouracil‐based treatment for solid cancers</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Cryotherapy versus control for preventing oral mucositis in adults receiving fluorouracil‐based treatment for solid cancers</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults** with solid cancers receiving fluorouracil‐based cancer treatment<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> cryotherapy<br/> <b>Comparison:</b> control (no treatment or routine care) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with cryotherapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral mucositis (any)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>728 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>444 per 1000<br/> (379 to 524) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.61<br/> (0.52 to 0.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>444<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral cryotherapy reduced the risk of developing oral mucositis by 39% (95% CI 28% to 48%). We would need to treat 4 people (95% CI 3 to 5 people) with oral cryotherapy to prevent 1 additional person from developing oral mucositis </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral mucositis (moderate + severe)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>530 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>276 per 1000<br/> (217 to 344) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.52<br/> (0.41 to 0.65) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>444<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral cryotherapy reduced the risk of developing moderate to severe oral mucositis by 48% (95% CI 35% to 59%). We would need to treat 4 people (95% CI 4 to 6 people) with oral cryotherapy to prevent 1 additional person from developing moderate to severe oral mucositis </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral mucositis (severe)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>300 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>120 per 1000<br/> (81 to 183) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.40<br/> (0.27 to 0.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>444<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral cryotherapy reduced the risk of severe oral mucositis by 60% (95% CI 39% to 73%). We would need to treat 6 people (95% CI 5 to 9 people) with oral cryotherapy to prevent 1 additional person from developing severe oral mucositis </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interruptions to cancer treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>400 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>176 per 1000<br/> (80 to 380) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.44<br/> (0.20 to 0.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral cryotherapy reduced the risk of treatment interruption by 56% (95% CI 5% to 80%). We would need to treat 5 people (95% CI 4 to 50 people) with oral cryotherapy to prevent 1 additional person from having a treatment interruption </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral pain (1 to 5 scale: 1 = never, 2 = 1 day of week, 3 = 2 to 3 days of week, 4 = most of week, 5 = 7 days of week) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean oral pain (1 to 5 scale) was 3.64</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean oral pain (1 to 5 scale) in the cryotherapy group was 1.93 lower (2.37 to 1.49 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The duration of oral pain experienced was less in the oral cryotherapy group (Additional <a href="#CD011552-tbl-0003">Table 1</a>) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Normalcy of diet (days of total parenteral nutrition)</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Duration of hospitalisation (days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> All 5 studies at high risk of performance and detection bias </p> <p><sup>2</sup> Single study at high risk of performance and detection bias </p> <p><sup>3</sup> Low sample size and wide confidence interval </p> <p><sup>4</sup> Indirect due to single study in 1 setting (in terms of country, healthcare system, and participants potentially differing from other countries) </p> <p>** There were no studies conducted on children</p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011552-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Cryotherapy versus control for preventing oral mucositis in adults receiving high‐dose melphalan‐based treatment prior to haematopoietic stem cell transplantation for haematological cancers</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Cryotherapy versus control for preventing oral mucositis in adults receiving high‐dose melphalan‐based treatment prior to haematopoietic stem cell transplantation for haematological cancers</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults** with haematological cancers receiving high‐dose melphalan‐based treatment prior to haematopoietic stem cell transplantation<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> cryotherapy<br/> <b>Comparison:</b> control (no treatment or routine care) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with cryotherapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral mucositis (any)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>824 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>486 per 1000<br/> (289 to 833) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.59<br/> (0.35 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>270<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral cryotherapy appears to reduce the risk of developing oral mucositis. However, there is great uncertainty about our estimate, and there is an extremely small chance of a 1% increase in the risk of developing oral mucositis compared to control. The point estimate suggests a 41% reduction in the risk of developing oral mucositis, with the confidence interval ranging from a 65% reduction to a 1% increase in risk. We would need to treat 3 people with oral cryotherapy to prevent 1 additional person from developing oral mucositis, with the confidence interval ranging from 2 people (to prevent 1 additional oral mucositis case) to 111 people to cause 1 additional person to develop oral mucositis </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral mucositis (moderate + severe)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>679 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>292 per 1000<br/> (115 to 741) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.43<br/> (0.17 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>270<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral cryotherapy appears to reduce the risk of developing moderate to severe oral mucositis. However, there is great uncertainty about our estimate, and there is a very small chance of a 9% increase in the risk of developing moderate to severe oral mucositis compared to control. The point estimate suggests a 57% reduction in the risk of developing moderate to severe oral mucositis, with the confidence interval ranging from an 83% reduction to a 9% increase in risk. We would need to treat 3 people with oral cryotherapy to prevent 1 additional person from developing moderate to severe oral mucositis, with the confidence interval ranging from 2 people (to prevent 1 additional moderate to severe oral mucositis case) to 17 people to cause 1 additional person to develop moderate to severe oral mucositis </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral mucositis (severe)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>427 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>162 per 1000<br/> (85 to 308) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.38<br/> (0.20 to 0.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>270<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral cryotherapy reduced the risk of developing severe oral mucositis by 62% (95% CI 28% to 80%). We would need to treat 4 people (95% CI 3 to 9 people) with oral cryotherapy to prevent 1 additional person from developing severe oral mucositis </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interruptions to cancer treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral pain on a 0 (no pain) to 10 (maximum pain) scale</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The weighted mean oral pain (0 to 10 scale) was 2.13</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean oral pain (0 to 10 scale) in the cryotherapy group was 1.5 lower (2.11 to 0.89 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral cryotherapy reduced oral pain by 70% although the clinical importance of a 1.5 point‐reduction on a 0 to 10 scale is questionable </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>1 study assessed this outcome but the data are currently unavailable as the study report and analysis have not yet been completed </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Normalcy of diet (days of total parenteral nutrition ‐ TPN)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of days of TPN was 7</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of days of TPN in the intervention group was 2.18 days fewer (4.33 to 0.03 fewer) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>5 6 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral cryotherapy reduced the duration of TPN by 2.18 days. There was some additional very low quality evidence, from a single small study at high risk of bias, reporting only median, range and P value, that oral cryotherapy reduced the number of days of TPN (Additional <a href="#CD011552-tbl-0003">Table 1</a>) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Duration of hospitalisation (days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of hospitalisation (days) was 0</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of hospitalisation (days) in the intervention group was 1.39 undefined fewer (2.97 fewer to 0.19 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>123<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There is insufficient evidence to show that oral cryotherapy reduces the duration of hospitalisation. This is supported by additional very low quality evidence, from a single small study at high risk of bias, reporting only median, range and P value, that there is insufficient evidence to show a reduction in this outcome (Additional <a href="#CD011552-tbl-0003">Table 1</a>) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>TPN:</b> total parenteral nutrition </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> All 5 studies at risk of performance and detection bias, with 1 study at added risk of attrition bias </p> <p><sup>2</sup> The I<sup>2</sup> value indicates that a considerable amount (&gt; 90%) of the variability in effect estimates is due to heterogeneity rather than chance </p> <p><sup>3</sup> Both studies at high risk of performance and detection bias </p> <p><sup>4</sup> Low sample size from 2 small studies </p> <p><sup>5</sup> Single study at high risk of performance and detection bias </p> <p><sup>6</sup> Low sample size and wide confidence interval </p> <p><sup>7</sup> Indirect due to single study in 1 setting (in terms of country, healthcare system, and participants potentially differing from other countries) </p> <p>** There were no studies conducted on children</p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011552-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011552-sec-0030"></div> <section id="CD011552-sec-0031"> <h3 class="title" id="CD011552-sec-0031">Description of the condition</h3> <p>Treating cancer with chemotherapy, radiotherapy of the head and neck, or targeted therapy can cause toxic oral side effects (<a href="./references#CD011552-bbs2-0033" title="Al‐DasooqiN , SonisST , BowenJM , BatemanE , BlijlevensN , GibsonRJ , et al. Emerging evidence on the pathobiology of mucositis. Supportive Care in Cancer2013;21(11):3233‐41. ">Al‐Dasooqi 2013</a>; <a href="./references#CD011552-bbs2-0054" title="ScullyC , SonisS , DizPD . Oral mucositis. Oral Diseases2006;12(3):229‐41. ">Scully 2006</a>; <a href="./references#CD011552-bbs2-0056" title="SonisST , EltingLS , KeefeD , PetersonDE , SchubertM , Hauer‐JensenM , et al. Perspectives on cancer therapy‐induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer2004;100(9 Suppl):1995‐2025. ">Sonis 2004</a>). Perhaps the most widely researched of these side effects is oral mucositis (<a href="./references#CD011552-bbs2-0033" title="Al‐DasooqiN , SonisST , BowenJM , BatemanE , BlijlevensN , GibsonRJ , et al. Emerging evidence on the pathobiology of mucositis. Supportive Care in Cancer2013;21(11):3233‐41. ">Al‐Dasooqi 2013</a>), which affects at least 75% of high risk patients (those receiving head and neck radiotherapy or high‐dose chemotherapy) (<a href="./references#CD011552-bbs2-0054" title="ScullyC , SonisS , DizPD . Oral mucositis. Oral Diseases2006;12(3):229‐41. ">Scully 2006</a>). Oral mucositis may be under‐reported in lower risk groups for various reasons: their tendency to be outpatients with less observation; less reporting of moderate mucositis; or patients and clinicians wishing to avoid any disruption to optimal cancer treatment (<a href="./references#CD011552-bbs2-0054" title="ScullyC , SonisS , DizPD . Oral mucositis. Oral Diseases2006;12(3):229‐41. ">Scully 2006</a>). </p> <p>Simply put, oral mucositis affects the oral mucosa (the mucous membrane of moist tissue lining the oral cavity) and can lead to the development of lesions (ulcers). However, the process that leads to oral mucositis is complex and multifactorial, with Sonis' five phase model being the currently accepted explanation for the sequence of events underlying the condition (<a href="./references#CD011552-bbs2-0056" title="SonisST , EltingLS , KeefeD , PetersonDE , SchubertM , Hauer‐JensenM , et al. Perspectives on cancer therapy‐induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer2004;100(9 Suppl):1995‐2025. ">Sonis 2004</a>; <a href="./references#CD011552-bbs2-0057" title="SonisST . Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncology2009;45(12):1015‐20. ">Sonis 2009</a>). </p> <p> <ol id="CD011552-list-0001"> <li> <p>Initiation: DNA damage caused by chemotherapy or radiotherapy results in the loss of ability to proliferate in the basal cells of the epithelium (the external layers of cells lining the oral mucosa). This produces reactive oxygen species (ROS). </p> </li> <li> <p>Primary damage response: Radiotherapy, chemotherapy, ROS, and DNA strand breaks all contribute to the activation of transcription factors such as nuclear factor kappa beta (NF‐Kβ), and sphingomyelinases. All this leads to the upregulation of pro‐inflammatory cytokines (e.g. tumour necrosis factor alpha ‐ TNF‐α), nitric oxide, ceramide, and matrix metalloproteinases, resulting in the thinning of the epithelium through tissue injury and cell death, culminating with the destruction of the oral mucosa. </p> </li> <li> <p>Signal amplification: Some of the molecules in the previous phase can lead to the exacerbation and prolonging of tissue injury through positive or negative feedback (e.g. TNF‐α can positively feedback on NF‐Kβ thus inducing more pro‐inflammatory cytokine production). </p> </li> <li> <p>Ulceration: Bacteria colonise ulcers and their cell wall products infiltrate the submucosa (the connective tissues beneath the oral mucosa), activating tissue macrophages (white blood cells that respond to infection or damaged/dead cells), which results in further production of pro‐inflammatory cytokines, inflammation, and pain. </p> </li> <li> <p>Healing: Signalling from the extracellular matrix of the submucosa results in epithelial proliferation and differentiation, and thus a thickening of the epithelium. The local oral flora are reinstated. </p> </li> </ol> </p> <p>Understanding of the pathobiology leading to mucosal toxicity as a result of targeted therapies (e.g. mammalian target of rapamycin (mTOR) inhibitor‐associated stomatitis ‐ mIAS) is currently limited, but it is thought to differ from chemotherapy‐ and radiotherapy‐induced mucositis, and the clinical presentation of the ulcers is more similar to aphthous stomatitis (<a href="./references#CD011552-bbs2-0033" title="Al‐DasooqiN , SonisST , BowenJM , BatemanE , BlijlevensN , GibsonRJ , et al. Emerging evidence on the pathobiology of mucositis. Supportive Care in Cancer2013;21(11):3233‐41. ">Al‐Dasooqi 2013</a>; <a href="./references#CD011552-bbs2-0035" title="Boers‐DoetsCB , Raber‐DurlacherJE , TreisterNS , EpsteinJB , ArendsAB , WiersmaDR , et al. Mammalian target of rapamycin inhibitor‐associated stomatitis. Future Oncology2013;9(12):1883‐92. ">Boers‐Doets 2013</a>; <a href="./references#CD011552-bbs2-0053" title="PetersonD , SrivastavaR , LallaR . Oral mucosal injury in oncology patients: perspectives on maturation of a field. Oral Diseases2015; Vol. 21, issue 2:133‐41. ">Peterson 2015</a>). </p> <p>Chemotherapy‐induced oral mucositis is regarded as an acute condition, with ulceration normally occurring one week after treatment, and resolving within three weeks of treatment (<a href="./references#CD011552-bbs2-0057" title="SonisST . Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncology2009;45(12):1015‐20. ">Sonis 2009</a>). Radiotherapy‐induced oral mucositis is chronic in nature, with ulceration normally occurring around two weeks into a seven‐week treatment cycle, and resolving three to four weeks after treatment has ended (<a href="./references#CD011552-bbs2-0057" title="SonisST . Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncology2009;45(12):1015‐20. ">Sonis 2009</a>). </p> <p>Ulceration is the most significant phase as it leads to pain of varying severity, and difficulties with eating, swallowing, and talking (<a href="./references#CD011552-bbs2-0054" title="ScullyC , SonisS , DizPD . Oral mucositis. Oral Diseases2006;12(3):229‐41. ">Scully 2006</a>). This in turn leads to the consumption of pain relief medication, requirement for nutritional support (e.g. a feeding tube), treatment of the oral mucositis, specialist oral hygiene care, increased medical appointments and use of staff and resources, and, in some instances, hospitalisation (<a href="./references#CD011552-bbs2-0045" title="JensenSB , PetersonDE . Oral mucosal injury caused by cancer therapies: current management and new frontiers in research. Journal of Oral Pathology &amp; Medicine2014;43(2):81‐90. ">Jensen 2014</a>; <a href="./references#CD011552-bbs2-0050" title="MillerM , KearneyN . Oral care for patients with cancer: a review of the literature. Cancer Nursing2001;24(4):241‐54. ">Miller 2001</a>; <a href="./references#CD011552-bbs2-0058" title="TrottiA , BellmLA , EpsteinJB , FrameD , FuchsHJ , GwedeCK , et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiotherapy and Oncology2003;66(3):253‐62. ">Trotti 2003</a>). Thus the negative impact on the quality of life of cancer patients, when they are already suffering, is severe (<a href="./references#CD011552-bbs2-0040" title="EltingLS , KeefeDM , SonisST , GardenAS , SpijkervetFK , BaraschA , et al. Patient‐reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer2008;113(10):2704‐13. ">Elting 2008</a>; <a href="./references#CD011552-bbs2-0041" title="EpsteinJB , EmertonS , KolbinsonDA , LeND , PhillipsN , Stevenson‐MooreP , et al. Quality of life and oral function following radiotherapy for head and neck cancer. Head &amp; Neck1999;21(1):1‐11. ">Epstein 1999</a>). Further problems can occur in immunosuppressed patients if whole bacteria on the ulcer surface cross into the underlying submucosa, potentially leading to bacteraemia and sepsis, which require antibiotics and hospitalisation, and can cause death (<a href="./references#CD011552-bbs2-0045" title="JensenSB , PetersonDE . Oral mucosal injury caused by cancer therapies: current management and new frontiers in research. Journal of Oral Pathology &amp; Medicine2014;43(2):81‐90. ">Jensen 2014</a>; <a href="./references#CD011552-bbs2-0053" title="PetersonD , SrivastavaR , LallaR . Oral mucosal injury in oncology patients: perspectives on maturation of a field. Oral Diseases2015; Vol. 21, issue 2:133‐41. ">Peterson 2015</a>; <a href="./references#CD011552-bbs2-0054" title="ScullyC , SonisS , DizPD . Oral mucositis. Oral Diseases2006;12(3):229‐41. ">Scully 2006</a>). </p> <p>Therefore, oral mucositis can be a dose‐limiting condition, disrupting a patient's optimal cancer treatment plan and consequentially decreasing their chances of survival (<a href="./references#CD011552-bbs2-0045" title="JensenSB , PetersonDE . Oral mucosal injury caused by cancer therapies: current management and new frontiers in research. Journal of Oral Pathology &amp; Medicine2014;43(2):81‐90. ">Jensen 2014</a>; <a href="./references#CD011552-bbs2-0053" title="PetersonD , SrivastavaR , LallaR . Oral mucosal injury in oncology patients: perspectives on maturation of a field. Oral Diseases2015; Vol. 21, issue 2:133‐41. ">Peterson 2015</a>; <a href="./references#CD011552-bbs2-0056" title="SonisST , EltingLS , KeefeD , PetersonDE , SchubertM , Hauer‐JensenM , et al. Perspectives on cancer therapy‐induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer2004;100(9 Suppl):1995‐2025. ">Sonis 2004</a>). The additional costs associated with oral mucositis can be significant, with one study reporting a median incremental cost of USD 18,515 per patient (<a href="./references#CD011552-bbs2-0051" title="NonzeeNJ , DandadeNA , PatelU , MarkossianT , AgulnikM , ArgirisA , et al. Evaluating the supportive care costs of severe radiochemotherapy‐induced mucositis and pharyngitis. Cancer2008;113(6):1446‐52. ">Nonzee 2008</a>). These costs have been reported to be as much as USD 42,749 more per patient when ulcerative oral mucositis is present (<a href="./references#CD011552-bbs2-0055" title="SonisST , OsterG , FuchsH , BellmL , BradfordWZ , EdelsbergJ , et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem‐cell transplantation. Journal of Clinical Oncology2001;19(8):2201‐5. ">Sonis 2001</a>). </p> </section> <section id="CD011552-sec-0032"> <h3 class="title" id="CD011552-sec-0032">Description of the intervention</h3> <p>Fluorouracil (5FU) is a common chemotherapy treatment for solid cancers and, in this setting, oral cryotherapy typically involves placing ice chips in the mouth five minutes prior to chemotherapy and continuing for 30 minutes (<a href="./references#CD011552-bbs2-0048" title="LallaRV , SonisST , PetersonDE . Management of oral mucositis in patients who have cancer. Dental Clinics of North America2008;52(1):61‐77. ">Lalla 2008</a>). In other settings, such as patients with haematological cancers receiving high‐dose melphalan prior to stem cell transplantation, oral cryotherapy is administered for longer periods of time, even as long as seven hours (<a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>). The ice chips are typically rounded to avoid any sharp edges or corners that may cause irritation to the patient, and also so that they can be easily moved around in the mouth (<a href="./references#CD011552-bbs2-0047" title="KaragözoğluS , Filiz UlusoyM . Chemotherapy: the effect of oral cryotherapy on the development of mucositis. Journal of Clinical Nursing2005;14(6):754‐65. ">Karagözoğlu 2005</a>). </p> <p>The advantages of using cryotherapy over other interventions are its availability, cost‐effectiveness, ease of administration, and safety (in terms of lack of side‐effects), and that it is well tolerated by patients (<a href="./references#CD011552-bbs2-0052" title="PetersonDE , OhrnK , BowenJ , FliednerM , LeesJ , LoprinziC , et al. Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Supportive Care in Cancer2013;21(1):327‐32. ">Peterson 2013</a>). </p> </section> <section id="CD011552-sec-0033"> <h3 class="title" id="CD011552-sec-0033">How the intervention might work</h3> <p>The use of ice chips in the mouth cools the oral tissues and causes the blood vessels to narrow (vasoconstriction), thus reducing blood flow to the area and therefore also restricting the amounts of the chemotherapy drugs delivered to the tissues (<a href="./references#CD011552-bbs2-0048" title="LallaRV , SonisST , PetersonDE . Management of oral mucositis in patients who have cancer. Dental Clinics of North America2008;52(1):61‐77. ">Lalla 2008</a>; <a href="./references#CD011552-bbs2-0052" title="PetersonDE , OhrnK , BowenJ , FliednerM , LeesJ , LoprinziC , et al. Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Supportive Care in Cancer2013;21(1):327‐32. ">Peterson 2013</a>; <a href="./references#CD011552-bbs2-0054" title="ScullyC , SonisS , DizPD . Oral mucositis. Oral Diseases2006;12(3):229‐41. ">Scully 2006</a>). Cryotherapy may only be effective in the prevention of oral mucositis in patients receiving chemotherapy drugs that have a short half‐life, such as bolus 5‐FU, bolus edatrexate, and high‐dose melphalan (<a href="./references#CD011552-bbs2-0048" title="LallaRV , SonisST , PetersonDE . Management of oral mucositis in patients who have cancer. Dental Clinics of North America2008;52(1):61‐77. ">Lalla 2008</a>; <a href="./references#CD011552-bbs2-0052" title="PetersonDE , OhrnK , BowenJ , FliednerM , LeesJ , LoprinziC , et al. Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Supportive Care in Cancer2013;21(1):327‐32. ">Peterson 2013</a>; <a href="./references#CD011552-bbs2-0054" title="ScullyC , SonisS , DizPD . Oral mucositis. Oral Diseases2006;12(3):229‐41. ">Scully 2006</a>). Considering the mechanism by which cryotherapy can prevent oral mucositis caused by chemotherapy, it is unclear whether or not it could have any effect on oral mucositis caused by radiotherapy (<a href="./references#CD011552-bbs2-0048" title="LallaRV , SonisST , PetersonDE . Management of oral mucositis in patients who have cancer. Dental Clinics of North America2008;52(1):61‐77. ">Lalla 2008</a>). It is also unclear whether or not cryotherapy could have any role in the prevention of targeted therapy‐induced stomatitis. </p> </section> <section id="CD011552-sec-0034"> <h3 class="title" id="CD011552-sec-0034">Why it is important to do this review</h3> <p>This review is the first of a series that will replace the previously published Cochrane review covering all interventions for the prevention of oral mucositis in patients with cancer receiving treatment (<a href="./references#CD011552-bbs2-0064" title="WorthingtonHV , ClarksonJE , BryanG , FurnessS , GlennyAM , LittlewoodA , et al. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews2011, Issue 4. [DOI: 10.1002/14651858.CD000978.pub5] ">Worthington 2011</a>). The Mucositis Study Group (MSG) of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) is a group that was set up in 1998 for the purpose of producing international evidence‐based clinical practice guidelines for managing mucositis (both oral and gastrointestinal), which they first published in 2004, with the latest update published in 2014 (<a href="./references#CD011552-bbs2-0049" title="LallaRV , BowenJ , BaraschA , EltingL , EpsteinJ , KeefeDM , et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer2014;120(10):1453‐61. ">Lalla 2014</a>). In order to facilitate the future updating of Cochrane reviews on this topic, and also to make them more usable to clinicians, guideline developers, and consumers, we have decided to divide the original Cochrane review into the same intervention categories as those used by MASCC/ISOO, which are as follows: </p> <p> <ul id="CD011552-list-0002"> <li> <p>basic oral care/good clinical practice;</p> </li> <li> <p>growth factors and cytokines;</p> </li> <li> <p>anti‐inflammatory agents;</p> </li> <li> <p>antimicrobials, mucosal coating agents, anaesthetics, and analgesics;</p> </li> <li> <p>laser and other light therapy;</p> </li> <li> <p>cryotherapy;</p> </li> <li> <p>natural and miscellaneous agents;</p> </li> <li> <p>amifostine.</p> </li> </ul> </p> <p>We believe that running in tandem with the MASCC/ISOO categories will enable the Cochrane reviews to more easily feed into such guidelines. We will also be able to be more thorough and rigorous in our assessment and summarising of the evidence in each of the categories, which was not feasible in a single Cochrane review approaching 150 included studies. </p> <p>It is also important to do this review as it is consistently shown to be the most used review produced by the Cochrane Oral Health Group (in terms of full‐text downloads). It was also ranked by an expert panel of oral medicine specialists as being the most important topic in the field of oral medicine in an international prioritisation exercise carried out by the Cochrane Oral Health Group in 2014 (<a href="./references#CD011552-bbs2-0062" title="WorthingtonH , ClarksonJ , WeldonJ . Priority oral health research identification for clinical decision‐making. Evidence‐based Dentistry2015;16(3):69‐71. ">Worthington 2015</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011552-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011552-sec-0035"></div> <p>To assess the effects of oral cryotherapy for preventing oral mucositis in patients with cancer who are receiving treatment. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011552-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011552-sec-0036"></div> <section id="CD011552-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011552-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included all randomised controlled trials (RCTs) of parallel design. It is possible to conduct cross‐over studies in this area as patients may receive several treatment sessions, with any mucositis completely healing in the periods between the sessions. However, we did not include cross‐over data as we cannot discount any period effects, with mucositis risk increasing as patients receive further cycles of treatment (<a href="./references#CD011552-bbs2-0054" title="ScullyC , SonisS , DizPD . Oral mucositis. Oral Diseases2006;12(3):229‐41. ">Scully 2006</a>; <a href="./references#CD011552-bbs2-0057" title="SonisST . Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncology2009;45(12):1015‐20. ">Sonis 2009</a>). Instead, we used the first‐period data only and treated such studies as parallel studies. </p> </section> <section id="CD011552-sec-0039"> <h4 class="title">Types of participants</h4> <p>We included all patients with cancer who are receiving treatment.</p> </section> <section id="CD011552-sec-0040"> <h4 class="title">Types of interventions</h4> <p>We included studies comparing oral cryotherapy for the prevention of oral mucositis against usual care, no treatment, or any other treatment to prevent oral mucositis. We also included studies comparing different regimens of oral cryotherapy against each other (head‐to‐head studies). We planned to include studies of oral mucositis caused by chemotherapy, radiotherapy, and targeted therapy. </p> <p>We excluded studies with 'complex' interventions for the prevention of mucositis, such as lasers plus cryotherapy versus lasers. We excluded studies assessing different cancer treatments where the primary outcome is survival/cure, with mucositis as a toxicity. </p> </section> <section id="CD011552-sec-0041"> <h4 class="title">Types of outcome measures</h4> <p>We are in agreement with <a href="./references#CD011552-bbs2-0061" title="WilliamsonPR , AltmanDG , BlazebyJM , ClarkeM , DevaneD , GargonE , et al. Developing core outcome sets for clinical trials: issues to consider. Trials2012;13:132. ">Williamson 2012</a> that, if clinical trials and systematic reviews are to be utilised, the outcomes assessed should be those considered important to patients, healthcare professionals, and other key stakeholders. If outcomes and outcome measures are inconsistent across studies, it will not be possible to compare and summarise research, and there is potential for outcome reporting bias, with the selective reporting of results based on statistical significance and favourability (<a href="./references#CD011552-bbs2-0036" title="ClarkeM . Standardising outcomes for clinical trials and systematic reviews. Trials2007;8:39. ">Clarke 2007</a>; <a href="./references#CD011552-bbs2-0038" title="DwanK , AltmanDG , ArnaizJA , BloomJ , ChanAW , CroninE , et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One2008;3(8):e3081. ">Dwan 2008</a>; <a href="./references#CD011552-bbs2-0060" title="WilliamsonPR , GambleC , AltmanDG , HuttonJL . Outcome selection bias in meta‐analysis. Statistical Methods in Medical Research2005;14(5):515‐24. ">Williamson 2005</a>). This can lead to exaggerated estimates of effect in systematic reviews of interventions, leading to an incorrect belief that an intervention is more beneficial that it truly is (<a href="./references#CD011552-bbs2-0036" title="ClarkeM . Standardising outcomes for clinical trials and systematic reviews. Trials2007;8:39. ">Clarke 2007</a>). It is thought that the way to address this problem is to develop disease‐ or condition‐specific core outcome sets to be used as a minimum when conducting and reporting clinical trials (<a href="./references#CD011552-bbs2-0036" title="ClarkeM . Standardising outcomes for clinical trials and systematic reviews. Trials2007;8:39. ">Clarke 2007</a>; <a href="./references#CD011552-bbs2-0061" title="WilliamsonPR , AltmanDG , BlazebyJM , ClarkeM , DevaneD , GargonE , et al. Developing core outcome sets for clinical trials: issues to consider. Trials2012;13:132. ">Williamson 2012</a>). </p> <p>Therefore we used the core outcome set produced by <a href="./references#CD011552-bbs2-0034" title="BellmLA , CunninghamG , DurnellL , EilersJ , EpsteinJB , FlemingT , et al. Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board. Cancer Investigation2002;20(5‐6):793‐800. ">Bellm 2002</a>, which is registered on the COMET (Core Outcome Measures in Effectiveness Trials) Initiative's website (<a href="http://www.comet-initiative.org" target="_blank">www.comet‐initiative.org</a>), and is the only core outcome set for oral mucositis known to us. </p> <section id="CD011552-sec-0042"> <h5 class="title">Primary outcomes</h5> <p>Mucositis incidence of any severity. We used mucositis measured on a 0 to 4 point scale (none to severe) and dichotomised it as any mucositis (0 versus 1+), moderate to severe mucositis (0 to 1 versus 2+), and severe mucositis (0 to 2 versus 3+). </p> <p>Some studies measure mucositis using a composite scale. If it was possible to extract the 'mucositis only' data from the total score, we would have included the data in the analyses. If it was not possible, we would have recorded the composite data in an additional table. </p> </section> <section id="CD011552-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD011552-list-0003"> <li> <p>Interruptions to cancer treatment.</p> </li> <li> <p>Oral pain.</p> </li> <li> <p>Quality of life.</p> </li> <li> <p>Normalcy of diet (including use of percutaneous endoscopic gastrostomy (PEG) feeding tubes or total parenteral nutrition (TPN)). </p> </li> <li> <p>Adverse events.</p> </li> <li> <p>Number of days in hospital.</p> </li> <li> <p>Number of days of treatment with opioid analgesics.</p> </li> <li> <p>Number of days unable to take medicine orally.</p> </li> </ul> </p> </section> </section> </section> <section id="CD011552-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <p>For the identification of studies included or considered for this review, we developed detailed search strategies for each database searched. These were based on the search strategy we developed for MEDLINE (Ovid) (<a href="./appendices#CD011552-sec-0169">Appendix 3</a>), which we revised appropriately for each database. The study design filter used by the Cochrane Oral Health Group was added to the search of the EMBASE database to limit the search to randomised controlled trials (<a href="./appendices#CD011552-sec-0170">Appendix 4</a>). </p> <section id="CD011552-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We searched the following electronic databases:</p> <p> <ul id="CD011552-list-0004"> <li> <p>the Cochrane Oral Health Group Trials Register (to 17 June 2015) (<a href="./appendices#CD011552-sec-0167">Appendix 1</a>); </p> </li> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL) (<i>Cochrane Library</i> 2015, Issue 5) (<a href="./appendices#CD011552-sec-0168">Appendix 2</a>); </p> </li> <li> <p>MEDLINE via Ovid (1946 to 17 June 2015) (<a href="./appendices#CD011552-sec-0169">Appendix 3</a>); </p> </li> <li> <p>EMBASE via Ovid (1980 to 17 June 2015) (<a href="./appendices#CD011552-sec-0170">Appendix 4</a>); </p> </li> <li> <p>CANCERLIT via PubMed (1950 to 17 June 2015) (<a href="./appendices#CD011552-sec-0171">Appendix 5</a>); </p> </li> <li> <p>CINAHL via EBSCO (1937 to 17 June 2015) (<a href="./appendices#CD011552-sec-0172">Appendix 6</a>). </p> </li> </ul> </p> <p>No restrictions were placed on the language or date of publication when searching the electronic databases. </p> </section> <section id="CD011552-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We searched the following databases for ongoing trials (<a href="./appendices#CD011552-sec-0173">Appendix 7</a>): </p> <p> <ul id="CD011552-list-0005"> <li> <p>US National Institutes of Health Trials Registry (<a href="http://clinicaltrials.gov" target="_blank">http://clinicaltrials.gov</a>) (to 17 June 2015); </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/default.aspx" target="_blank">http://apps.who.int/trialsearch/default.aspx</a>) (to 17 June 2015). </p> </li> </ul> </p> <p>We only included handsearching done as part of the Cochrane Worldwide Handsearching Programme and uploaded to CENTRAL. </p> </section> </section> <section id="CD011552-sec-0047"> <h3 class="title" id="CD011552-sec-0047">Data collection and analysis</h3> <section id="CD011552-sec-0048"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently screened the titles and abstracts retrieved from the electronic searches. We obtained full‐text copies of all studies that appeared to meet the inclusion criteria of the review, or where there was insufficient information in the title or abstract to make a clear judgement. Two review authors independently assessed the full text copies for eligibility and attempted to resolve any disagreements through discussion. We consulted a third review author if we could not resolve disagreements. </p> <p>On assessing the full text article, we discarded any studies that clearly did not meet the inclusion criteria. We recorded all other studies that did not meet the inclusion criteria, along with reasons for exclusion, in the <a href="./references#CD011552-sec-0184" title="">Characteristics of excluded studies</a> table. </p> </section> <section id="CD011552-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently extracted the data from each included study using a specially designed data extraction form, which we first piloted on a small sample of studies. We contacted study authors for clarification or missing data where necessary and feasible. We resolved any disagreements through discussion, consulting a third review author to achieve consensus when necessary. </p> <p>We recorded the following data for each included study in the <a href="./references#CD011552-sec-0183" title="">Characteristics of included studies</a> table. </p> <p> <ul id="CD011552-list-0006"> <li> <p>Trial design, location, number of centres, recruitment period.</p> </li> <li> <p>Inclusion/exclusion criteria, age and gender of participants, number randomised/analysed, any other potentially important prognostic factors (e.g. cancer type, cancer treatment, etc.). </p> </li> <li> <p>Detailed description of the intervention and comparator, including timing and duration. Information on compliance with the cryotherapy regimen. </p> </li> <li> <p>Details of the outcomes reported, including method of assessment and time(s) assessed.</p> </li> <li> <p>Details of sample size calculations, adverse effects, funding sources, declarations/conflicts of interest. </p> </li> </ul> </p> </section> <section id="CD011552-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed the risk of bias of each included study using the Cochrane domain‐based, two‐part tool as described in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011552-bbs2-0044" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We contacted study authors for clarification or missing information where necessary and feasible. We resolved any disagreements through discussion, consulting a third review author to achieve consensus when necessary. </p> <p>We completed a 'Risk of bias' table for each included study. For each domain of risk of bias, we first described what was reported to have happened in the study. This provided the rationale for our judgement of whether that domain was at low, high, or unclear risk of bias. </p> <p>We assessed the following domains:</p> <p> <ol id="CD011552-list-0007"> <li> <p>sequence generation (selection bias);</p> </li> <li> <p>allocation concealment (selection bias);</p> </li> <li> <p>blinding of participants and personnel (performance bias);</p> </li> <li> <p>blinding of outcome assessment (detection bias);</p> </li> <li> <p>incomplete outcome data (attrition bias);</p> </li> <li> <p>selective outcome reporting (reporting bias);</p> </li> <li> <p>other bias.</p> </li> </ol> </p> <p>We categorised the overall risk of bias of individual studies. Studies were categorised as being at low, high, or unclear risk of bias according to the following criteria: </p> <p> <ul id="CD011552-list-0008"> <li> <p>low risk of bias (plausible bias unlikely to seriously alter the results) if all domains were at low risk of bias; </p> </li> <li> <p>high risk of bias (plausible bias that seriously weakens confidence in the results) if one or more domains were at high risk of bias; or </p> </li> <li> <p>unclear risk of bias (plausible bias that raises some doubt about the results) if one or more domains were at unclear risk of bias. </p> </li> </ul> </p> <p>We also presented the 'Risk of bias' summary graphically (<a href="#CD011552-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD011552-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011552-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> </section> <section id="CD011552-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>For continuous outcomes (e.g. oral pain on a visual analogue scale) where studies used the same scale, we used the mean values and standard deviations (SDs) reported in the studies in order to express the estimate of effect as mean difference (MD) with 95% confidence interval (CI). Where different scales were used, we would have considered expressing the treatment effect as standardised mean difference (SMD) with 95% CI. </p> <p>For dichotomous outcomes (e.g. mucositis of any severity/no mucositis), we expressed the estimate of effect as a risk ratio (RR) with 95% CI. </p> </section> <section id="CD011552-sec-0052"> <h4 class="title">Unit of analysis issues</h4> <p>The participant was the unit of analysis.</p> </section> <section id="CD011552-sec-0053"> <h4 class="title">Dealing with missing data</h4> <p>We attempted to contact the author(s) of all included studies, where feasible, for clarification, missing data, and details of any other outcomes that may have been measured but not reported. We used the methods described in Section 7.7.3 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> to estimate missing SDs (<a href="./references#CD011552-bbs2-0044" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We did not use any other statistical methods or perform any further imputation to account for missing data. </p> </section> <section id="CD011552-sec-0054"> <h4 class="title">Assessment of heterogeneity</h4> <p>When a sufficient number of studies were included in any meta‐analyses, we assessed clinical heterogeneity by examining the characteristics of the studies, the similarity between the types of participants, the interventions, and the outcomes. We also assessed heterogeneity statistically using a Chi<sup>2</sup> test, where a P value &lt; 0.1 indicates statistically significant heterogeneity. We quantified heterogeneity using the I<sup>2</sup> statistic. A guide to interpretation of the I<sup>2</sup> statistic given in Section 9.5.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> is as follows (<a href="http://archie.cochrane.org/sections/documents/view?document=z1212041522488842326831797537651%26format=REVMAN#REF-Higgins-2011" target="_blank">Higgins 2011</a>): </p> <p> <ul id="CD011552-list-0009"> <li> <p>0% to 40%: might not be important;</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity;</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity;</p> </li> <li> <p>75% to 100%: considerable heterogeneity.</p> </li> </ul> </p> </section> <section id="CD011552-sec-0055"> <h4 class="title">Assessment of reporting biases</h4> <p>If at least 10 studies were included in a meta‐analysis, we planned to assess publication bias according to the recommendations on testing for funnel plot asymmetry (<a href="./references#CD011552-bbs2-0039" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315(7109):629‐34. ">Egger 1997</a>), as described in Section 10.4 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011552-bbs2-0044" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). If asymmetry was identified, we would examine possible causes. We were not able to assess publication bias in this way because, although we had a sufficient number of studies in our meta‐analyses for the primary outcome, they were split into subgroups containing less than 10 studies, with no pooling of the subgroup totals. </p> </section> <section id="CD011552-sec-0056"> <h4 class="title">Data synthesis</h4> <p>We only carried out meta‐analyses where there were studies of similar comparisons reporting the same outcomes. We combined MDs for continuous data, and RRs for dichotomous data. Our general approach was to use a random‐effects model. With this approach, the CIs for the average intervention effect were wider than those that would have been obtained using a fixed‐effect approach, leading to a more conservative interpretation. </p> <p>We used an additional table to report the results from studies not suitable for inclusion in a meta‐analysis. </p> </section> <section id="CD011552-sec-0057"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We carried out subgroup analyses according to type of cancer treatment. We stated in the protocol that we would also use both type of cancer treatment and cancer type as categories for subgroup analyses. However, these categories are very closely related, so it did not make sense to do so. We also would have considered age group (children versus adults) as a category for subgroup analyses, if there had been sufficient numbers of studies with these differing populations. </p> </section> <section id="CD011552-sec-0058"> <h4 class="title">Sensitivity analysis</h4> <p>As all studies were at high risk of both performance and detection bias, it was not possible to test the robustness of our results by performing sensitivity analyses based on excluding the studies at unclear or high risk of bias from the analyses. </p> <p>If any meta‐analyses had included several small studies and a single very large study, we would have undertaken a sensitivity analysis comparing the effect estimates from both random‐effects and fixed‐effect models. If these were different we would have reported on both analyses as part of the results section, and we would have considered possible interpretation. </p> <section id="CD011552-sec-0059"> <h5 class="title">Presentation of main results</h5> <p>We produced a 'Summary of findings' table for each comparison that included more than one study, and for the main outcomes (listed below). We produced a separate table for each of the two main cancer treatment types in this review: treatment of solid cancers and treatment of haematological cancers. We used GRADE methods (<a href="./references#CD011552-bbs2-0042" title="GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490. ">GRADE 2004</a>), and <a href="./references#CD011552-bbs2-0043" title="McMaster University. GRADEpro. McMaster University, 2014. ">GRADEpro 2014</a> software. We assessed the quality of the body of evidence for each comparison and outcome by considering the overall risk of bias of the included studies, the directness of the evidence, the inconsistency of the results, the precision of the estimates, and the risk of publication bias. We categorised the quality of each body of evidence as high, moderate, low, or very low. </p> <p>Main outcomes:</p> <p> <ul id="CD011552-list-0010"> <li> <p>mucositis incidence;</p> </li> <li> <p>interruptions to cancer treatment;</p> </li> <li> <p>oral pain;</p> </li> <li> <p>quality of life;</p> </li> <li> <p>normalcy of diet;</p> </li> <li> <p>adverse events;</p> </li> <li> <p>number of days in hospital.</p> </li> </ul> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011552-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011552-sec-0060"></div> <section id="CD011552-sec-0061"> <h3 class="title">Description of studies</h3> <section id="CD011552-sec-0062"> <h4 class="title">Results of the search</h4> <p>The electronic searches retrieved 745 references to studies. After removing duplicates, this figure was reduced to 426. We examined the titles and abstracts of these references and discarded all but 40 with no further assessment. Where possible, we obtained full‐text copies of these 40 potentially relevant references, and we linked any multiple references to the same study under a single study ID, resulting in a total of 32 studies. We excluded 11 studies (11 references) at this stage. The remaining 21 studies (29 references) appeared to meet our inclusion criteria and we were able to include 14 of these studies (20 references). Of the remaining 7 studies (9 references), 5 studies (7 references) are awaiting assessment due to insufficient information in the abstract or trials registry record to allow inclusion in the review, and 2 studies (2 references) are ongoing. We present this process as a flow chart in <a href="#CD011552-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD011552-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD011552-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD011552-sec-0063"> <h4 class="title">Included studies</h4> <p>Fourteen studies were included in this review (<i>see</i><a href="./references#CD011552-sec-0183" title="">Characteristics of included studies</a> tables). </p> <section id="CD011552-sec-0064"> <h5 class="title">Characteristics of the trial designs and settings</h5> <p>Twelve studies were of parallel design, with the remaining two studies using a cross‐over design (<a href="./references#CD011552-bbs2-0008" title="DoseAM , MahoodD , LoprinziCL , GaineyD , SorensenJM , TherneauT . A controlled trial of oral cryotherapy for preventing stomatitis in patients receiving 5‐fluorouracil (5FU) plus leucovorin (LV). A North Central Cancer Treatment Group and Mayo Clinic Study. Proceedings of the 26th Annual Meeting of the American Society of Clinical Oncology; 1990, May 20‐22; Washington DC, USA. 1990; Vol. 9:321, Abstract no: 1242. MahoodDJ , DoseAM , LoprinziCL , VeederMH , AthmannLM , ThereauTM , et al. Inhibition of fluorouracil‐induced stomatitis by oral cryotherapy. Journal of Clinical Oncology1991;9(3):449‐52. ">Mahood 1991</a>; <a href="./references#CD011552-bbs2-0009" title="RockeLK , LoprinziCL , LeeJK , KunselmanSJ , IversonRK , FinckG , et al. A randomized clinical trial of two different durations or oral cryotherapy for prevention of 5‐fluorouracil‐related stomatitis. Cancer1993;72(7):2234‐8. ">Rocke 1993</a>). We treated the cross‐over studies as parallel studies by using only the first‐period data. Eleven studies had two arms, whilst two studies had three arms (<a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>; <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>), one of which was excluded from <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a> as we felt that the comparison of the third group, using supersaturated calcium phosphate rinse (Caphosol®), with the co‐intervention of cryotherapy plus saline may be confounded. Another study had four arms, with one of those arms being excluded from this review because it involved treating oral mucositis rather than preventing it (<a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>). Four studies were conducted in the USA (<a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0008" title="DoseAM , MahoodD , LoprinziCL , GaineyD , SorensenJM , TherneauT . A controlled trial of oral cryotherapy for preventing stomatitis in patients receiving 5‐fluorouracil (5FU) plus leucovorin (LV). A North Central Cancer Treatment Group and Mayo Clinic Study. Proceedings of the 26th Annual Meeting of the American Society of Clinical Oncology; 1990, May 20‐22; Washington DC, USA. 1990; Vol. 9:321, Abstract no: 1242. MahoodDJ , DoseAM , LoprinziCL , VeederMH , AthmannLM , ThereauTM , et al. Inhibition of fluorouracil‐induced stomatitis by oral cryotherapy. Journal of Clinical Oncology1991;9(3):449‐52. ">Mahood 1991</a>; <a href="./references#CD011552-bbs2-0009" title="RockeLK , LoprinziCL , LeeJK , KunselmanSJ , IversonRK , FinckG , et al. A randomized clinical trial of two different durations or oral cryotherapy for prevention of 5‐fluorouracil‐related stomatitis. Cancer1993;72(7):2234‐8. ">Rocke 1993</a>; <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>), three in Iran (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>; <a href="./references#CD011552-bbs2-0005" title="KakoeiS , GhassemiA , NakhaeiNR . Effect of cryotherapy on oral mucositis in patients with head and neck cancers receiving radiotherapy. International Journal of Radiation Research2013;11(2):117‐20. ">Kakoei 2013</a>), two in Italy (<a href="./references#CD011552-bbs2-0002" title="CascinuS , FedeliA , FedeliSL , CatalanoG . Oral cooling (cryotherapy), an effective treatment for the prevention of 5‐fluorouracil‐induced stomatitis. European Journal of Cancer. Part B, Oral Oncology1994;30B(4):234‐6. ">Cascinu 1994</a>; <a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>), and one in each of Turkey (<a href="./references#CD011552-bbs2-0006" title="KatranciN , OvayoluN , OvayoluO , SevincA . Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy ‐ a randomized controlled trial. European Journal of Oncology Nursing2012;16(4):339‐44. ">Katranci 2012</a>), Canada (<a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>), Denmark (<a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>), Sweden (<a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>), and China (<a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>). There were nine single‐centre studies, one with two centres (<a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>), and four that were multicentre but were unclear about how many centres were involved (<a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>; <a href="./references#CD011552-bbs2-0008" title="DoseAM , MahoodD , LoprinziCL , GaineyD , SorensenJM , TherneauT . A controlled trial of oral cryotherapy for preventing stomatitis in patients receiving 5‐fluorouracil (5FU) plus leucovorin (LV). A North Central Cancer Treatment Group and Mayo Clinic Study. Proceedings of the 26th Annual Meeting of the American Society of Clinical Oncology; 1990, May 20‐22; Washington DC, USA. 1990; Vol. 9:321, Abstract no: 1242. MahoodDJ , DoseAM , LoprinziCL , VeederMH , AthmannLM , ThereauTM , et al. Inhibition of fluorouracil‐induced stomatitis by oral cryotherapy. Journal of Clinical Oncology1991;9(3):449‐52. ">Mahood 1991</a>; <a href="./references#CD011552-bbs2-0009" title="RockeLK , LoprinziCL , LeeJK , KunselmanSJ , IversonRK , FinckG , et al. A randomized clinical trial of two different durations or oral cryotherapy for prevention of 5‐fluorouracil‐related stomatitis. Cancer1993;72(7):2234‐8. ">Rocke 1993</a>; <a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>). Five studies did not report the duration of the trial from start to finish, but the remaining studies ranged in total duration from six months to five years. </p> <p>Eight studies reported details of a sample size calculation: two of these studies achieved their required sample size (<a href="./references#CD011552-bbs2-0005" title="KakoeiS , GhassemiA , NakhaeiNR . Effect of cryotherapy on oral mucositis in patients with head and neck cancers receiving radiotherapy. International Journal of Radiation Research2013;11(2):117‐20. ">Kakoei 2013</a>; <a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>), two did not (<a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>; <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>), three were unclear whether or not the sample size requirements were met (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>; <a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>), and the remaining study did not use the primary outcome of oral mucositis incidence/severity to calculate the required sample size (<a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>). Six studies did not mention sample size calculation (<a href="./references#CD011552-bbs2-0002" title="CascinuS , FedeliA , FedeliSL , CatalanoG . Oral cooling (cryotherapy), an effective treatment for the prevention of 5‐fluorouracil‐induced stomatitis. European Journal of Cancer. Part B, Oral Oncology1994;30B(4):234‐6. ">Cascinu 1994</a>; <a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>; <a href="./references#CD011552-bbs2-0006" title="KatranciN , OvayoluN , OvayoluO , SevincA . Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy ‐ a randomized controlled trial. European Journal of Oncology Nursing2012;16(4):339‐44. ">Katranci 2012</a>; <a href="./references#CD011552-bbs2-0008" title="DoseAM , MahoodD , LoprinziCL , GaineyD , SorensenJM , TherneauT . A controlled trial of oral cryotherapy for preventing stomatitis in patients receiving 5‐fluorouracil (5FU) plus leucovorin (LV). A North Central Cancer Treatment Group and Mayo Clinic Study. Proceedings of the 26th Annual Meeting of the American Society of Clinical Oncology; 1990, May 20‐22; Washington DC, USA. 1990; Vol. 9:321, Abstract no: 1242. MahoodDJ , DoseAM , LoprinziCL , VeederMH , AthmannLM , ThereauTM , et al. Inhibition of fluorouracil‐induced stomatitis by oral cryotherapy. Journal of Clinical Oncology1991;9(3):449‐52. ">Mahood 1991</a>; <a href="./references#CD011552-bbs2-0009" title="RockeLK , LoprinziCL , LeeJK , KunselmanSJ , IversonRK , FinckG , et al. A randomized clinical trial of two different durations or oral cryotherapy for prevention of 5‐fluorouracil‐related stomatitis. Cancer1993;72(7):2234‐8. ">Rocke 1993</a>; <a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>). </p> <p>Eleven studies reported on funding sources, all of which were in the form of independent funding from government, charities or universities. The remaining three studies did not report any funding sources (<a href="./references#CD011552-bbs2-0002" title="CascinuS , FedeliA , FedeliSL , CatalanoG . Oral cooling (cryotherapy), an effective treatment for the prevention of 5‐fluorouracil‐induced stomatitis. European Journal of Cancer. Part B, Oral Oncology1994;30B(4):234‐6. ">Cascinu 1994</a>; <a href="./references#CD011552-bbs2-0006" title="KatranciN , OvayoluN , OvayoluO , SevincA . Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy ‐ a randomized controlled trial. European Journal of Oncology Nursing2012;16(4):339‐44. ">Katranci 2012</a>; <a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>). Four studies declared that there were no conflicts of interest (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0006" title="KatranciN , OvayoluN , OvayoluO , SevincA . Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy ‐ a randomized controlled trial. European Journal of Oncology Nursing2012;16(4):339‐44. ">Katranci 2012</a>; <a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>; <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>), whilst the other ten studies did not mention conflicts of interest. </p> </section> <section id="CD011552-sec-0065"> <h5 class="title">Characteristics of the participants</h5> <p>There were 1316 participants randomised to interventions (including only the intervention groups relevant to this review), of which 1280 were included in the studies' analyses. Age ranged from 8 to 85 years across the studies, with mean or median ages ranging between 36 to 63 years. However, only one study reported the inclusion of children, although this was a small minority (<a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>). In general, there were more males than females in the studies. Only one study included more females than males, but this was because 50% of the participants had breast cancer (<a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>). One study involved participants undergoing radiotherapy to the head and neck, with the remaining studies involving participants undergoing chemotherapy. No studies involved targeted therapy. </p> <section id="CD011552-sec-0066"> <h6 class="title">Solid cancers</h6> <p>In eight studies, the participants had solid cancers. In four of these studies, the majority of cancers were gastrointestinal, colorectal, and breast (<a href="./references#CD011552-bbs2-0002" title="CascinuS , FedeliA , FedeliSL , CatalanoG . Oral cooling (cryotherapy), an effective treatment for the prevention of 5‐fluorouracil‐induced stomatitis. European Journal of Cancer. Part B, Oral Oncology1994;30B(4):234‐6. ">Cascinu 1994</a>; <a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>; <a href="./references#CD011552-bbs2-0006" title="KatranciN , OvayoluN , OvayoluO , SevincA . Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy ‐ a randomized controlled trial. European Journal of Oncology Nursing2012;16(4):339‐44. ">Katranci 2012</a>; <a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>), whilst two studies did not state the types of cancers involved (<a href="./references#CD011552-bbs2-0008" title="DoseAM , MahoodD , LoprinziCL , GaineyD , SorensenJM , TherneauT . A controlled trial of oral cryotherapy for preventing stomatitis in patients receiving 5‐fluorouracil (5FU) plus leucovorin (LV). A North Central Cancer Treatment Group and Mayo Clinic Study. Proceedings of the 26th Annual Meeting of the American Society of Clinical Oncology; 1990, May 20‐22; Washington DC, USA. 1990; Vol. 9:321, Abstract no: 1242. MahoodDJ , DoseAM , LoprinziCL , VeederMH , AthmannLM , ThereauTM , et al. Inhibition of fluorouracil‐induced stomatitis by oral cryotherapy. Journal of Clinical Oncology1991;9(3):449‐52. ">Mahood 1991</a>; <a href="./references#CD011552-bbs2-0009" title="RockeLK , LoprinziCL , LeeJK , KunselmanSJ , IversonRK , FinckG , et al. A randomized clinical trial of two different durations or oral cryotherapy for prevention of 5‐fluorouracil‐related stomatitis. Cancer1993;72(7):2234‐8. ">Rocke 1993</a>), one study included only head and neck cancers (<a href="./references#CD011552-bbs2-0005" title="KakoeiS , GhassemiA , NakhaeiNR . Effect of cryotherapy on oral mucositis in patients with head and neck cancers receiving radiotherapy. International Journal of Radiation Research2013;11(2):117‐20. ">Kakoei 2013</a>), and one study included only bone cancer (osteosarcoma) (<a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>). The cancer treatment in these studies of solid cancers mostly involved fluorouracil (5FU), normally in conjunction with leucovorin (<a href="./references#CD011552-bbs2-0002" title="CascinuS , FedeliA , FedeliSL , CatalanoG . Oral cooling (cryotherapy), an effective treatment for the prevention of 5‐fluorouracil‐induced stomatitis. European Journal of Cancer. Part B, Oral Oncology1994;30B(4):234‐6. ">Cascinu 1994</a>; <a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>; <a href="./references#CD011552-bbs2-0006" title="KatranciN , OvayoluN , OvayoluO , SevincA . Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy ‐ a randomized controlled trial. European Journal of Oncology Nursing2012;16(4):339‐44. ">Katranci 2012</a>; <a href="./references#CD011552-bbs2-0008" title="DoseAM , MahoodD , LoprinziCL , GaineyD , SorensenJM , TherneauT . A controlled trial of oral cryotherapy for preventing stomatitis in patients receiving 5‐fluorouracil (5FU) plus leucovorin (LV). A North Central Cancer Treatment Group and Mayo Clinic Study. Proceedings of the 26th Annual Meeting of the American Society of Clinical Oncology; 1990, May 20‐22; Washington DC, USA. 1990; Vol. 9:321, Abstract no: 1242. MahoodDJ , DoseAM , LoprinziCL , VeederMH , AthmannLM , ThereauTM , et al. Inhibition of fluorouracil‐induced stomatitis by oral cryotherapy. Journal of Clinical Oncology1991;9(3):449‐52. ">Mahood 1991</a>; <a href="./references#CD011552-bbs2-0009" title="RockeLK , LoprinziCL , LeeJK , KunselmanSJ , IversonRK , FinckG , et al. A randomized clinical trial of two different durations or oral cryotherapy for prevention of 5‐fluorouracil‐related stomatitis. Cancer1993;72(7):2234‐8. ">Rocke 1993</a>; <a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>). The study on participants with head and neck cancers was the only study included in this review that assessed the effects of oral cryotherapy for preventing oral mucositis in people receiving radiotherapy‐only (<a href="./references#CD011552-bbs2-0005" title="KakoeiS , GhassemiA , NakhaeiNR . Effect of cryotherapy on oral mucositis in patients with head and neck cancers receiving radiotherapy. International Journal of Radiation Research2013;11(2):117‐20. ">Kakoei 2013</a>). In the remaining study including participants with osteosarcoma (<a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>), the cancer treatment was high‐dose methotrexate plus vincristine and leucovorin. </p> </section> <section id="CD011552-sec-0067"> <h6 class="title">Haematological cancers</h6> <p>In five studies, the participants had haematological cancers: multiple myeloma (<a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>; <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>), Hodgkin lymphoma, non‐Hodgkin lymphoma, and multiple myeloma (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>), and mixed (<a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>). The cancer treatment in these studies involved high‐dose melphalan (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>; <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>), or low‐dose methotrexate for preventing graft‐versus‐host disease (GVHD), which is the rejection of donor cells, after allogeneic (cells from a donor) stem cell transplantation (<a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>). </p> <p>One study included one participant in each group (2.6%) with solid cancer (testicular), with the remaining participants all having a mixture of haematological cancers (<a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>). The cancer treatment in this study was mixed, with the majority (73%) of participants receiving either high‐dose melphalan or BEAC regimen (carmustine, etoposide, cytarabine and cyclophosphamide). </p> <p>In these six studies involving haematological cancers, participants also had haematopoietic stem cell transplantation (HSCT) following chemotherapy. However, in <a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>, the authors assessed the effects of oral cryotherapy for preventing oral mucositis due to further chemotherapy given after HSCT for the purpose of preventing GVHD. </p> </section> </section> <section id="CD011552-sec-0068"> <h5 class="title">Characteristics of the interventions and comparisons</h5> <p>One study compared different durations (30 minutes versus 60 minutes) of oral cryotherapy (<a href="./references#CD011552-bbs2-0009" title="RockeLK , LoprinziCL , LeeJK , KunselmanSJ , IversonRK , FinckG , et al. A randomized clinical trial of two different durations or oral cryotherapy for prevention of 5‐fluorouracil‐related stomatitis. Cancer1993;72(7):2234‐8. ">Rocke 1993</a>). Eight studies compared oral cryotherapy against no treatment (<a href="./references#CD011552-bbs2-0002" title="CascinuS , FedeliA , FedeliSL , CatalanoG . Oral cooling (cryotherapy), an effective treatment for the prevention of 5‐fluorouracil‐induced stomatitis. European Journal of Cancer. Part B, Oral Oncology1994;30B(4):234‐6. ">Cascinu 1994</a>; <a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>; <a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>; <a href="./references#CD011552-bbs2-0005" title="KakoeiS , GhassemiA , NakhaeiNR . Effect of cryotherapy on oral mucositis in patients with head and neck cancers receiving radiotherapy. International Journal of Radiation Research2013;11(2):117‐20. ">Kakoei 2013</a>; <a href="./references#CD011552-bbs2-0008" title="DoseAM , MahoodD , LoprinziCL , GaineyD , SorensenJM , TherneauT . A controlled trial of oral cryotherapy for preventing stomatitis in patients receiving 5‐fluorouracil (5FU) plus leucovorin (LV). A North Central Cancer Treatment Group and Mayo Clinic Study. Proceedings of the 26th Annual Meeting of the American Society of Clinical Oncology; 1990, May 20‐22; Washington DC, USA. 1990; Vol. 9:321, Abstract no: 1242. MahoodDJ , DoseAM , LoprinziCL , VeederMH , AthmannLM , ThereauTM , et al. Inhibition of fluorouracil‐induced stomatitis by oral cryotherapy. Journal of Clinical Oncology1991;9(3):449‐52. ">Mahood 1991</a>; <a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>; <a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>; <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>). In four of these studies, both the oral cryotherapy group and control group received standard oral care (<a href="./references#CD011552-bbs2-0005" title="KakoeiS , GhassemiA , NakhaeiNR . Effect of cryotherapy on oral mucositis in patients with head and neck cancers receiving radiotherapy. International Journal of Radiation Research2013;11(2):117‐20. ">Kakoei 2013</a>; <a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>; <a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>; <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>), so the comparison can be thought of as being oral cryotherapy versus no treatment (no extra treatment). One of these four studies also had a supersaturated calcium phosphate rinse (Caphosol®) group which we excluded from this review because we did not consider this intervention versus cryotherapy plus saline rinse to be an eligible comparison, due to potential confounding from the latter co‐intervention (<a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>). Another four studies compared oral cryotherapy against some form of standard oral care: saline rinse (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>), unspecified (<a href="./references#CD011552-bbs2-0006" title="KatranciN , OvayoluN , OvayoluO , SevincA . Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy ‐ a randomized controlled trial. European Journal of Oncology Nursing2012;16(4):339‐44. ">Katranci 2012</a>). One of these studies had a third intervention group that received chlorhexidine rinse (<a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>). The remaining study had three eligible intervention groups and compared oral cryotherapy against leucovorin rinse and high‐dose leucovorin rinse (<a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>). </p> <p>Most studies used ice chips for cooling the oral cavity, with one study also allowing an alternative option of using popsicles (a flavoured ice lolly) (<a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>), and another study allowed the alternative option of ice‐cold water (<a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>). Two studies used ice cubes (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0005" title="KakoeiS , GhassemiA , NakhaeiNR . Effect of cryotherapy on oral mucositis in patients with head and neck cancers receiving radiotherapy. International Journal of Radiation Research2013;11(2):117‐20. ">Kakoei 2013</a>), possibly suggesting a larger size of ice pieces, whereas another two studies used crushed ice (<a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>; <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>), possibly suggesting smaller ice pieces. One study exclusively used ice water (<a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>). </p> <p>The duration of treatment with oral cryotherapy varied widely according to chemotherapy regimen, and was unclear in five studies (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0002" title="CascinuS , FedeliA , FedeliSL , CatalanoG . Oral cooling (cryotherapy), an effective treatment for the prevention of 5‐fluorouracil‐induced stomatitis. European Journal of Cancer. Part B, Oral Oncology1994;30B(4):234‐6. ">Cascinu 1994</a>; <a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>; <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>; <a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>). The most consistent cryotherapy schedule was in those participants receiving fluorouracil (5FU) and leucovorin, and typically consisted of 30 minutes (45 minutes in <a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>; 60 minutes in half the participants in <a href="./references#CD011552-bbs2-0009" title="RockeLK , LoprinziCL , LeeJK , KunselmanSJ , IversonRK , FinckG , et al. A randomized clinical trial of two different durations or oral cryotherapy for prevention of 5‐fluorouracil‐related stomatitis. Cancer1993;72(7):2234‐8. ">Rocke 1993</a>) per day for five consecutive days. The longest duration of oral cryotherapy was seven hours (<a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>). </p> </section> <section id="CD011552-sec-0069"> <h5 class="title">Characteristics of the outcomes</h5> <p>We wrote to authors of 11 of the included studies to ask if they had measured any other outcomes than those mentioned in the study reports. We did not write to authors of three of the included studies as they were published before the year 2000 and we thought it was unfeasible to obtain any extra data (<a href="./references#CD011552-bbs2-0002" title="CascinuS , FedeliA , FedeliSL , CatalanoG . Oral cooling (cryotherapy), an effective treatment for the prevention of 5‐fluorouracil‐induced stomatitis. European Journal of Cancer. Part B, Oral Oncology1994;30B(4):234‐6. ">Cascinu 1994</a>; <a href="./references#CD011552-bbs2-0008" title="DoseAM , MahoodD , LoprinziCL , GaineyD , SorensenJM , TherneauT . A controlled trial of oral cryotherapy for preventing stomatitis in patients receiving 5‐fluorouracil (5FU) plus leucovorin (LV). A North Central Cancer Treatment Group and Mayo Clinic Study. Proceedings of the 26th Annual Meeting of the American Society of Clinical Oncology; 1990, May 20‐22; Washington DC, USA. 1990; Vol. 9:321, Abstract no: 1242. MahoodDJ , DoseAM , LoprinziCL , VeederMH , AthmannLM , ThereauTM , et al. Inhibition of fluorouracil‐induced stomatitis by oral cryotherapy. Journal of Clinical Oncology1991;9(3):449‐52. ">Mahood 1991</a>; <a href="./references#CD011552-bbs2-0009" title="RockeLK , LoprinziCL , LeeJK , KunselmanSJ , IversonRK , FinckG , et al. A randomized clinical trial of two different durations or oral cryotherapy for prevention of 5‐fluorouracil‐related stomatitis. Cancer1993;72(7):2234‐8. ">Rocke 1993</a>). The authors of one study have since provided us with data for two outcomes not reported in their study: 'interruptions to cancer treatment' and 'oral pain' (<a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>). </p> <section id="CD011552-sec-0070"> <h6 class="title">Primary outcome</h6> <p>For the primary outcome of oral mucositis, we were interested in both the presence/absence of oral mucositis, and also different levels of severity. All 14 included studies measured oral mucositis. Eleven studies used the WHO 0 to 4 scale, or a scale based on this. Three studies used the National Cancer Institute common toxicity criteria (NCI‐CTC) 0 to 4 scale (<a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>; <a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>). The WHO and NCI‐CTC scales include both subjective and objective elements, and are highly comparable (<a href="./appendices#CD011552-sec-0174">Appendix 8</a>), such that it is not necessary to use standardised mean difference when including both types of measurement in a meta‐analysis. One study used a modified version of the Oral Mucositis Assessment Scale (OMAS) as the primary tool for measurement of oral mucositis, but provided us with full data according to the WHO scale (<a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>). The OMAS is an objective scale, measuring ulceration (0 to 3 scale) and erythema (0 to 2 scale) at nine different sites in the oral cavity (<a href="./appendices#CD011552-sec-0174">Appendix 8</a>). </p> <p>Eight studies reported the data in our preferred format which was the maximum oral mucositis score, on a 0 to 4 scale, experienced by each participant over the length of the study (<a href="./references#CD011552-bbs2-0002" title="CascinuS , FedeliA , FedeliSL , CatalanoG . Oral cooling (cryotherapy), an effective treatment for the prevention of 5‐fluorouracil‐induced stomatitis. European Journal of Cancer. Part B, Oral Oncology1994;30B(4):234‐6. ">Cascinu 1994</a>; <a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>; <a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>; <a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0008" title="DoseAM , MahoodD , LoprinziCL , GaineyD , SorensenJM , TherneauT . A controlled trial of oral cryotherapy for preventing stomatitis in patients receiving 5‐fluorouracil (5FU) plus leucovorin (LV). A North Central Cancer Treatment Group and Mayo Clinic Study. Proceedings of the 26th Annual Meeting of the American Society of Clinical Oncology; 1990, May 20‐22; Washington DC, USA. 1990; Vol. 9:321, Abstract no: 1242. MahoodDJ , DoseAM , LoprinziCL , VeederMH , AthmannLM , ThereauTM , et al. Inhibition of fluorouracil‐induced stomatitis by oral cryotherapy. Journal of Clinical Oncology1991;9(3):449‐52. ">Mahood 1991</a>; <a href="./references#CD011552-bbs2-0009" title="RockeLK , LoprinziCL , LeeJK , KunselmanSJ , IversonRK , FinckG , et al. A randomized clinical trial of two different durations or oral cryotherapy for prevention of 5‐fluorouracil‐related stomatitis. Cancer1993;72(7):2234‐8. ">Rocke 1993</a>; <a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>; <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>). One study reported the incidence of any oral mucositis (i.e. grades 1 to 4), but appeared to selectively report the incidence of each grade on a single day quite early in the study (i.e. not the maximum score experienced by each participant over the length of the study) (<a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>). Four studies reported the mean oral mucositis score on multiple assessment days (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0005" title="KakoeiS , GhassemiA , NakhaeiNR . Effect of cryotherapy on oral mucositis in patients with head and neck cancers receiving radiotherapy. International Journal of Radiation Research2013;11(2):117‐20. ">Kakoei 2013</a>; <a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>; <a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>), whilst the remaining study reported the incidence of each oral mucositis grade on multiple assessment days (<a href="./references#CD011552-bbs2-0006" title="KatranciN , OvayoluN , OvayoluO , SevincA . Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy ‐ a randomized controlled trial. European Journal of Oncology Nursing2012;16(4):339‐44. ">Katranci 2012</a>). </p> <p>We wrote to all authors who reported means or on multiple assessment days or both, to request incidence data in the form of a single table reporting the maximum oral mucositis score (on a 0 to 4 scale) experienced by each participant over the length of the study. The authors of two studies supplied us with the data in this format (<a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>; <a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>), and another author supplied us with incidence data, but on multiple assessment days (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>). We decided to use the data on the day with the highest incidence of grades &gt; 0 (day 7) because, in this study, this probably most closely equates to the maximum score experienced per participant (as reported in the majority of other studies in the meta‐analyses). For the other study reporting incidence data (<a href="./references#CD011552-bbs2-0006" title="KatranciN , OvayoluN , OvayoluO , SevincA . Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy ‐ a randomized controlled trial. European Journal of Oncology Nursing2012;16(4):339‐44. ">Katranci 2012</a>), but on multiple assessment days, we received no response from the authors, so we again used the data on the day with the highest incidence of grades &gt; 0 (day 14), although we are not sure how valid this is because there was still a high incidence of severe oral mucositis at day 21. For mean scores on multiple assessment days, we used the day with the highest control group mean and recorded the results in an additional table. </p> <p>The majority of studies assessed oral mucositis at multiple timepoints over approximately four weeks (<a href="./references#CD011552-bbs2-0002" title="CascinuS , FedeliA , FedeliSL , CatalanoG . Oral cooling (cryotherapy), an effective treatment for the prevention of 5‐fluorouracil‐induced stomatitis. European Journal of Cancer. Part B, Oral Oncology1994;30B(4):234‐6. ">Cascinu 1994</a>; <a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>; <a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0008" title="DoseAM , MahoodD , LoprinziCL , GaineyD , SorensenJM , TherneauT . A controlled trial of oral cryotherapy for preventing stomatitis in patients receiving 5‐fluorouracil (5FU) plus leucovorin (LV). A North Central Cancer Treatment Group and Mayo Clinic Study. Proceedings of the 26th Annual Meeting of the American Society of Clinical Oncology; 1990, May 20‐22; Washington DC, USA. 1990; Vol. 9:321, Abstract no: 1242. MahoodDJ , DoseAM , LoprinziCL , VeederMH , AthmannLM , ThereauTM , et al. Inhibition of fluorouracil‐induced stomatitis by oral cryotherapy. Journal of Clinical Oncology1991;9(3):449‐52. ">Mahood 1991</a>; <a href="./references#CD011552-bbs2-0009" title="RockeLK , LoprinziCL , LeeJK , KunselmanSJ , IversonRK , FinckG , et al. A randomized clinical trial of two different durations or oral cryotherapy for prevention of 5‐fluorouracil‐related stomatitis. Cancer1993;72(7):2234‐8. ">Rocke 1993</a>; <a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>; <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>), with some assessing it at multiple timepoints over three weeks (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>; <a href="./references#CD011552-bbs2-0006" title="KatranciN , OvayoluN , OvayoluO , SevincA . Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy ‐ a randomized controlled trial. European Journal of Oncology Nursing2012;16(4):339‐44. ">Katranci 2012</a>; <a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>), and the remaining studies assessing it at multiple timepoints over 10 to 14 days (<a href="./references#CD011552-bbs2-0005" title="KakoeiS , GhassemiA , NakhaeiNR . Effect of cryotherapy on oral mucositis in patients with head and neck cancers receiving radiotherapy. International Journal of Radiation Research2013;11(2):117‐20. ">Kakoei 2013</a>; <a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>; <a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>). Where participants had multiple cycles of treatment, we only reported the results for the first cycle. </p> <p>When studies reported oral mucositis data assessed separately by physicians and participants, we generally chose to use the physician‐judgement as we felt that this may be the more objective of the two, and therefore potentially less biased. There was one exception where only the participant‐judged data was reported in the study as there was no significant difference between that and the physician‐judgement (<a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>). </p> <p>To summarise, we were able to include the primary outcome data for 13 of the included studies: 11 in the comparison of cryotherapy versus control (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0002" title="CascinuS , FedeliA , FedeliSL , CatalanoG . Oral cooling (cryotherapy), an effective treatment for the prevention of 5‐fluorouracil‐induced stomatitis. European Journal of Cancer. Part B, Oral Oncology1994;30B(4):234‐6. ">Cascinu 1994</a>; <a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>; <a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>; <a href="./references#CD011552-bbs2-0006" title="KatranciN , OvayoluN , OvayoluO , SevincA . Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy ‐ a randomized controlled trial. European Journal of Oncology Nursing2012;16(4):339‐44. ">Katranci 2012</a>; <a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0008" title="DoseAM , MahoodD , LoprinziCL , GaineyD , SorensenJM , TherneauT . A controlled trial of oral cryotherapy for preventing stomatitis in patients receiving 5‐fluorouracil (5FU) plus leucovorin (LV). A North Central Cancer Treatment Group and Mayo Clinic Study. Proceedings of the 26th Annual Meeting of the American Society of Clinical Oncology; 1990, May 20‐22; Washington DC, USA. 1990; Vol. 9:321, Abstract no: 1242. MahoodDJ , DoseAM , LoprinziCL , VeederMH , AthmannLM , ThereauTM , et al. Inhibition of fluorouracil‐induced stomatitis by oral cryotherapy. Journal of Clinical Oncology1991;9(3):449‐52. ">Mahood 1991</a>; <a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>; <a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>; <a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>; <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>); one in the comparison of different durations of cryotherapy (<a href="./references#CD011552-bbs2-0009" title="RockeLK , LoprinziCL , LeeJK , KunselmanSJ , IversonRK , FinckG , et al. A randomized clinical trial of two different durations or oral cryotherapy for prevention of 5‐fluorouracil‐related stomatitis. Cancer1993;72(7):2234‐8. ">Rocke 1993</a>); and one in the comparison of cryotherapy versus leucovorin rinses (<a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>). </p> </section> <section id="CD011552-sec-0071"> <h6 class="title">Secondary outcomes</h6> <section id="CD011552-sec-0072"> <p><b>Interruptions to cancer treatment</b></p> <p>No studies reported this important outcome, but the authors of one study responded to our email request and provided us with both dichotomous (event) data and continuous data, the latter in the form of 'days of interruption' (<a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>). </p> </section> <section id="CD011552-sec-0073"> <p><b>Oral pain</b></p> <p>Four studies reported oral pain (<a href="./references#CD011552-bbs2-0005" title="KakoeiS , GhassemiA , NakhaeiNR . Effect of cryotherapy on oral mucositis in patients with head and neck cancers receiving radiotherapy. International Journal of Radiation Research2013;11(2):117‐20. ">Kakoei 2013</a>; <a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>; <a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>), another study measured oral pain but the study report is currently being written and the data are undergoing analysis (<a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>), and the authors of a further study responded to our email request and provided us with oral pain data (<a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>). Only two of these five studies reported data that we were able to combine in a meta‐analysis (<a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>), which was the mean oral pain score on a 0 to 10 scale for the study period. Another study also measured oral pain on a 0 to 10 scale, but did not report any usable data in the form of mean and standard deviation for the study period (<a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>). One study reported mean pain scores on multiple assessment days but did not describe the scale used, and therefore we were unable to use the data for meta‐analysis (<a href="./references#CD011552-bbs2-0005" title="KakoeiS , GhassemiA , NakhaeiNR . Effect of cryotherapy on oral mucositis in patients with head and neck cancers receiving radiotherapy. International Journal of Radiation Research2013;11(2):117‐20. ">Kakoei 2013</a>). The authors of one study provided us with data measured on a 1 to 5 scale representing the duration of time for which pain was experienced, unlike the other studies where the score represented pain intensity (<a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>). We decided to present these data in an additional table. It is not clear what scale was used in the remaining study for which the data are not yet available (<a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>). </p> </section> <section id="CD011552-sec-0074"> <p><b>Quality of life</b></p> <p>No studies reported this outcome. The authors of one study have confirmed that quality of life was measured using the Patient‐Reported Oral Mucositis Symptom (PROMS) scale, but the data are currently unavailable as the study report and analysis have not yet been completed (<a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>). </p> </section> <section id="CD011552-sec-0075"> <p><b>Normalcy of diet</b></p> <p>Two studies reported the duration, measured in days, of total parenteral nutrition (TPN) (<a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>). However, one of these studies reported a median and range for each group, rather than mean and standard deviation, so we were unable to use the data in our analysis (<a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>). Another study reported the functional intake of food and fluids on a 1 to 5 scale, but we were unable to use the data that were presented in a mixed‐effect regression model (<a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>). </p> </section> <section id="CD011552-sec-0076"> <p><b>Adverse events</b></p> <p>It was difficult to assess adverse effects in many cases due to the difficulty to distinguish between effects caused by oral cryotherapy and those caused by various cancer treatments. It also did not make sense to formally meta‐analyse data from comparisons of oral cryotherapy with no treatment. Furthermore, in the context of cancer treatment, and with no serious effects being expected from sucking ice, we considered this outcome to be of limited importance in this particular review (whereas it may be more important in our reviews of other potentially more harmful interventions for preventing oral mucositis e.g. growth factors and cytokines). We therefore decided to report this outcome in a narrative format. </p> <p>Four studies did not mention adverse effects (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>; <a href="./references#CD011552-bbs2-0005" title="KakoeiS , GhassemiA , NakhaeiNR . Effect of cryotherapy on oral mucositis in patients with head and neck cancers receiving radiotherapy. International Journal of Radiation Research2013;11(2):117‐20. ">Kakoei 2013</a>; <a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>), whilst the quality of reporting for this outcome varied between the remaining nine studies. </p> </section> <section id="CD011552-sec-0077"> <p><b>Number of days in hospital</b></p> <p>Three studies reported this outcome (<a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>; <a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>). We were able to combine the data for two studies, but the third study reported the median and range for each group, and we were therefore unable to use the data (<a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>). </p> </section> <section id="CD011552-sec-0078"> <p><b>Number of days of treatment with opioid analgesics</b></p> <p>Two studies reported this outcome (<a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>), but one reported the median and range for each group, and we were therefore unable to use the data (<a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>). A further study has measured 'narcotic use' but the data are currently unavailable as the study report and analysis have not yet been completed, and we do not know how this outcome was measured (<a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>). </p> </section> <section id="CD011552-sec-0079"> <p><b>Number of days unable to take medicine orally</b></p> <p>No studies reported this outcome.</p> </section> </section> </section> </section> <section id="CD011552-sec-0080"> <h4 class="title">Excluded studies</h4> <p>We excluded 11 studies from this review for the following reasons.</p> <p> <ul id="CD011552-list-0011"> <li> <p>Not a randomised controlled trial (RCT): non‐random allocation to groups (<a href="./references#CD011552-bbs2-0019" title="KaragözoğluS , Filiz UlusoyM . Chemotherapy: the effect of oral cryotherapy on the development of mucositis. Journal of Clinical Nursing2005;14(6):754‐65. ">Karagozoglu 2005</a>; <a href="./references#CD011552-bbs2-0023" title="PapadeasE , NaxakisS , RigaM , KalofonosCh . Prevention of 5‐fluorouracil‐related stomatitis by oral cryotherapy: a randomized controlled study. European Journal Oncology Nursing2007;11(1):60‐5. ">Papadeas 2007</a>; <a href="./references#CD011552-bbs2-0025" title="SatoA , Saisho‐HattoriT , KoizumiY , MinegishiM , IinumaK , ImaizumiM . Prophylaxis of mucosal toxicity by oral propantheline and cryotherapy in children with malignancies undergoing myeloablative chemo‐radiotherapy. The Tohoku Journal of Experimental Medicine2006;210(4):315‐20. ">Sato 2006</a>); used historical controls (<a href="./references#CD011552-bbs2-0015" title="AisaY , MoriT , KudoM , YashimaT , KondoS , YokoyamaA , et al. Oral cryotherapy for the prevention of high‐dose melphalan‐induced stomatitis in allogeneic hematopoietic stem cell transplant recipients. Supportive Care in Cancer2005;13(4):266‐9. ">Aisa 2005</a>; <a href="./references#CD011552-bbs2-0020" title="MoriT , YamazakiR , AisaY , NakazatoT , KudoM , YashimaT , et al. Brief oral cryotherapy for the prevention of high‐dose melphalan‐induced stomatitis in allogeneic hematopoietic stem cell transplant recipients. Supportive Care in Cancer2006;14(4):392‐5. ">Mori 2006</a>); translation to English confirmed it was case series (<a href="./references#CD011552-bbs2-0022" title="OhyamaW , KanoY , AkutsuM , TsunodaS . Ice ball cryotherapy for chemotherapy‐induced mucositis. Gan To Kagaku Ryoho1994;21(15):2675‐7. ">Ohyama 1994</a>). </p> </li> <li> <p>Unclear if RCT and authors have not provided clarification (<a href="./references#CD011552-bbs2-0024" title="SatoA , KumagaiS , SakakiK , MorikawaH , SongST , MoriS . Inhibition of 5‐fluorouracil‐cisplatin‐induced stomatitis by oral cryotherapy: use of an ice‐bar containing fibrinolysin and deoxyribonuclease comiben (Elase). Gan To Kagaku Ryoho1997;24(9):1135‐9. ">Sato 1997</a>). </p> </li> <li> <p>Cross‐over study with no reporting of first‐period data (<a href="./references#CD011552-bbs2-0016" title="BaydarM , DikilitasM , SevincA , AydogduI . Prevention of oral mucositis due to 5‐fluorouracil treatment with oral cryotherapy. Journal of the National Medical Association2005;97(8):1161‐4. ">Baydar 2005</a>; <a href="./references#CD011552-bbs2-0017" title="CastelinoF , Devi ElsaS , JyothiRK . Effectiveness of plain ice cubes versus flavoured ice cubes in preventing oral mucositis associated with injection 5‐fluorouracil among cancer patients. International Journal of Nursing Education Scholarship2011;3(2):38‐40. ">Castelino 2011</a>; <a href="./references#CD011552-bbs2-0021" title="NikolettiS , HydeS , ShawT , MyersH , KristjansonLJ . Comparison of plain ice and flavoured ice for preventing oral mucositis associated with the use of 5 fluorouracil. Journal of Clinical Nursing2005;14(6):750‐3. ">Nikoletti 2005</a>). </p> </li> <li> <p>Confounding due to co‐interventions and therefore not possible to attribute effect to cryotherapy (<a href="./references#CD011552-bbs2-0018" title="dePaula EduardoF , BezinelliLM , daGraça LopesRM , Nascimento SobrinhoJJ , HamerschlakN , CorreaL . Efficacy of cryotherapy associated with laser therapy for decreasing severity of melphalan‐induced oral mucositis during hematological stem‐cell transplantation: a prospective clinical study. Hematological Oncology2014 [Epub ahead of print]. ">de Paula Eduardo 2014</a>). </p> </li> </ul> </p> </section> </section> <section id="CD011552-sec-0081"> <h3 class="title">Risk of bias in included studies</h3> <section id="CD011552-sec-0082"> <h4 class="title">Allocation</h4> <section id="CD011552-sec-0083"> <h5 class="title">Random sequence generation</h5> <p>Eight studies described an adequate method of random sequence generation (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>; <a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>; <a href="./references#CD011552-bbs2-0005" title="KakoeiS , GhassemiA , NakhaeiNR . Effect of cryotherapy on oral mucositis in patients with head and neck cancers receiving radiotherapy. International Journal of Radiation Research2013;11(2):117‐20. ">Kakoei 2013</a>; <a href="./references#CD011552-bbs2-0006" title="KatranciN , OvayoluN , OvayoluO , SevincA . Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy ‐ a randomized controlled trial. European Journal of Oncology Nursing2012;16(4):339‐44. ">Katranci 2012</a>; <a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>; <a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>; <a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>), and the authors of three further studies responded to our requests for further information (<a href="./references#CD011552-bbs2-0002" title="CascinuS , FedeliA , FedeliSL , CatalanoG . Oral cooling (cryotherapy), an effective treatment for the prevention of 5‐fluorouracil‐induced stomatitis. European Journal of Cancer. Part B, Oral Oncology1994;30B(4):234‐6. ">Cascinu 1994</a>; <a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>), which clarified that their methods were adequate. Therefore we assessed 11 studies as being at low risk of bias for this domain. The remaining three studies only stated that participants were randomised but did not describe their methods, so they were assessed as being at unclear risk of bias for this domain (<a href="./references#CD011552-bbs2-0008" title="DoseAM , MahoodD , LoprinziCL , GaineyD , SorensenJM , TherneauT . A controlled trial of oral cryotherapy for preventing stomatitis in patients receiving 5‐fluorouracil (5FU) plus leucovorin (LV). A North Central Cancer Treatment Group and Mayo Clinic Study. Proceedings of the 26th Annual Meeting of the American Society of Clinical Oncology; 1990, May 20‐22; Washington DC, USA. 1990; Vol. 9:321, Abstract no: 1242. MahoodDJ , DoseAM , LoprinziCL , VeederMH , AthmannLM , ThereauTM , et al. Inhibition of fluorouracil‐induced stomatitis by oral cryotherapy. Journal of Clinical Oncology1991;9(3):449‐52. ">Mahood 1991</a>; <a href="./references#CD011552-bbs2-0009" title="RockeLK , LoprinziCL , LeeJK , KunselmanSJ , IversonRK , FinckG , et al. A randomized clinical trial of two different durations or oral cryotherapy for prevention of 5‐fluorouracil‐related stomatitis. Cancer1993;72(7):2234‐8. ">Rocke 1993</a>; <a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>). </p> </section> <section id="CD011552-sec-0084"> <h5 class="title">Allocation concealment</h5> <p>Two studies provided details of how the random sequence was concealed from those involved in the study (<a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>; <a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>), with a further five studies providing details through correspondence (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0002" title="CascinuS , FedeliA , FedeliSL , CatalanoG . Oral cooling (cryotherapy), an effective treatment for the prevention of 5‐fluorouracil‐induced stomatitis. European Journal of Cancer. Part B, Oral Oncology1994;30B(4):234‐6. ">Cascinu 1994</a>; <a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>; <a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>). Therefore we assessed seven studies as being at low risk of bias for this domain. The remaining seven studies did not mention any methods used to conceal the random sequence, and we assessed them as being at unclear risk of bias (<a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>; <a href="./references#CD011552-bbs2-0005" title="KakoeiS , GhassemiA , NakhaeiNR . Effect of cryotherapy on oral mucositis in patients with head and neck cancers receiving radiotherapy. International Journal of Radiation Research2013;11(2):117‐20. ">Kakoei 2013</a>; <a href="./references#CD011552-bbs2-0006" title="KatranciN , OvayoluN , OvayoluO , SevincA . Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy ‐ a randomized controlled trial. European Journal of Oncology Nursing2012;16(4):339‐44. ">Katranci 2012</a>; <a href="./references#CD011552-bbs2-0008" title="DoseAM , MahoodD , LoprinziCL , GaineyD , SorensenJM , TherneauT . A controlled trial of oral cryotherapy for preventing stomatitis in patients receiving 5‐fluorouracil (5FU) plus leucovorin (LV). A North Central Cancer Treatment Group and Mayo Clinic Study. Proceedings of the 26th Annual Meeting of the American Society of Clinical Oncology; 1990, May 20‐22; Washington DC, USA. 1990; Vol. 9:321, Abstract no: 1242. MahoodDJ , DoseAM , LoprinziCL , VeederMH , AthmannLM , ThereauTM , et al. Inhibition of fluorouracil‐induced stomatitis by oral cryotherapy. Journal of Clinical Oncology1991;9(3):449‐52. ">Mahood 1991</a>; <a href="./references#CD011552-bbs2-0009" title="RockeLK , LoprinziCL , LeeJK , KunselmanSJ , IversonRK , FinckG , et al. A randomized clinical trial of two different durations or oral cryotherapy for prevention of 5‐fluorouracil‐related stomatitis. Cancer1993;72(7):2234‐8. ">Rocke 1993</a>; <a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>; <a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>). </p> <p>Overall, seven studies are at low risk of selection bias, meaning that we assessed both of the above domains as being at low risk of bias (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0002" title="CascinuS , FedeliA , FedeliSL , CatalanoG . Oral cooling (cryotherapy), an effective treatment for the prevention of 5‐fluorouracil‐induced stomatitis. European Journal of Cancer. Part B, Oral Oncology1994;30B(4):234‐6. ">Cascinu 1994</a>; <a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>; <a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>; <a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>; <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>). The remaining seven studies are at unclear risk of selection bias because one or both of the above domains were rated as unclear (<a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>; <a href="./references#CD011552-bbs2-0005" title="KakoeiS , GhassemiA , NakhaeiNR . Effect of cryotherapy on oral mucositis in patients with head and neck cancers receiving radiotherapy. International Journal of Radiation Research2013;11(2):117‐20. ">Kakoei 2013</a>; <a href="./references#CD011552-bbs2-0006" title="KatranciN , OvayoluN , OvayoluO , SevincA . Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy ‐ a randomized controlled trial. European Journal of Oncology Nursing2012;16(4):339‐44. ">Katranci 2012</a>; <a href="./references#CD011552-bbs2-0008" title="DoseAM , MahoodD , LoprinziCL , GaineyD , SorensenJM , TherneauT . A controlled trial of oral cryotherapy for preventing stomatitis in patients receiving 5‐fluorouracil (5FU) plus leucovorin (LV). A North Central Cancer Treatment Group and Mayo Clinic Study. Proceedings of the 26th Annual Meeting of the American Society of Clinical Oncology; 1990, May 20‐22; Washington DC, USA. 1990; Vol. 9:321, Abstract no: 1242. MahoodDJ , DoseAM , LoprinziCL , VeederMH , AthmannLM , ThereauTM , et al. Inhibition of fluorouracil‐induced stomatitis by oral cryotherapy. Journal of Clinical Oncology1991;9(3):449‐52. ">Mahood 1991</a>; <a href="./references#CD011552-bbs2-0009" title="RockeLK , LoprinziCL , LeeJK , KunselmanSJ , IversonRK , FinckG , et al. A randomized clinical trial of two different durations or oral cryotherapy for prevention of 5‐fluorouracil‐related stomatitis. Cancer1993;72(7):2234‐8. ">Rocke 1993</a>; <a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>; <a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>). </p> </section> </section> <section id="CD011552-sec-0085"> <h4 class="title">Blinding</h4> <section id="CD011552-sec-0086"> <h5 class="title">Blinding of participants and personnel (performance bias)</h5> <p>It is not possible to blind participants or personnel to whether or not oral cryotherapy has been allocated. Knowledge of treatment allocation could affect expectations and behaviours (e.g. control group participants may take other interventions). Therefore we judged all 14 studies to be at high risk of performance bias. </p> </section> <section id="CD011552-sec-0087"> <h5 class="title">Blinding of outcome assessment (detection bias)</h5> <p>The subjective elements involved in the World Health Organisation (WHO) and National Cancer Institute common toxicity criteria (NCI‐CTC) tools, which were used to measure oral mucositis in the studies included in this review (<a href="./appendices#CD011552-sec-0174">Appendix 8</a>), require the patient's assessment of pain/soreness and their ability to swallow. Even if blinding of outcome assessment is attempted, we do not believe it is feasible. Therefore we judged all 14 studies to be at high risk of detection bias. </p> </section> </section> <section id="CD011552-sec-0088"> <h4 class="title">Incomplete outcome data</h4> <p>Only two studies were at high risk of attrition bias (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>), both due to differential attrition between groups, which may have been linked to prognosis. The remaining 12 studies had negligible or no attrition and we assessed them as being at low risk of attrition bias. </p> </section> <section id="CD011552-sec-0089"> <h4 class="title">Selective reporting</h4> <p>Three studies were at high risk of selective reporting bias. One of these studies reported oral pain, which was not stated in the trials registry record or the methods section of the study report (<a href="./references#CD011552-bbs2-0005" title="KakoeiS , GhassemiA , NakhaeiNR . Effect of cryotherapy on oral mucositis in patients with head and neck cancers receiving radiotherapy. International Journal of Radiation Research2013;11(2):117‐20. ">Kakoei 2013</a>). It is possible that the decision to report this outcome was based on statistical significance. Another study stated only that there was no significant differences for oral pain, but reported no data (<a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>). The remaining study only reported the incidence of each grade of oral mucositis on day 4, despite stating that it was measured on the day of chemotherapy and day 10 (<a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>). We assessed the other 11 studies as being at low risk of selective reporting bias as we could detect no obvious problems. </p> </section> <section id="CD011552-sec-0090"> <h4 class="title">Other potential sources of bias</h4> <p>We did not consider there to be any issues arising from other potential sources of bias in any of the studies and we therefore assessed them all as being at low risk of bias for this domain. </p> <section id="CD011552-sec-0091"> <h5 class="title">Overall risk of bias</h5> <p>All fourteen studies were assessed as being at high overall risk of bias (<a href="#CD011552-fig-0001">Figure 1</a>). </p> </section> </section> </section> <section id="CD011552-sec-0092"> <h3 class="title" id="CD011552-sec-0092">Effects of interventions</h3> <p>See: <a href="./full#CD011552-tbl-0001"><b>Summary of findings for the main comparison</b> Cryotherapy versus control for preventing oral mucositis in adults receiving fluorouracil‐based treatment for solid cancers</a>; <a href="./full#CD011552-tbl-0002"><b>Summary of findings 2</b> Cryotherapy versus control for preventing oral mucositis in adults receiving high‐dose melphalan‐based treatment prior to haematopoietic stem cell transplantation for haematological cancers</a> </p> <section id="CD011552-sec-0093"> <h4 class="title">Comparison 1: Cryotherapy versus control (standard care or no treatment)</h4> <section id="CD011552-sec-0094"> <h5 class="title">Oral mucositis (any)</h5> <section id="CD011552-sec-0095"> <h6 class="title">Fluorouracil (5FU) treatment for solid cancers</h6> <p>Five studies (<a href="./references#CD011552-bbs2-0002" title="CascinuS , FedeliA , FedeliSL , CatalanoG . Oral cooling (cryotherapy), an effective treatment for the prevention of 5‐fluorouracil‐induced stomatitis. European Journal of Cancer. Part B, Oral Oncology1994;30B(4):234‐6. ">Cascinu 1994</a>; <a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>; <a href="./references#CD011552-bbs2-0006" title="KatranciN , OvayoluN , OvayoluO , SevincA . Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy ‐ a randomized controlled trial. European Journal of Oncology Nursing2012;16(4):339‐44. ">Katranci 2012</a>; <a href="./references#CD011552-bbs2-0008" title="DoseAM , MahoodD , LoprinziCL , GaineyD , SorensenJM , TherneauT . A controlled trial of oral cryotherapy for preventing stomatitis in patients receiving 5‐fluorouracil (5FU) plus leucovorin (LV). A North Central Cancer Treatment Group and Mayo Clinic Study. Proceedings of the 26th Annual Meeting of the American Society of Clinical Oncology; 1990, May 20‐22; Washington DC, USA. 1990; Vol. 9:321, Abstract no: 1242. MahoodDJ , DoseAM , LoprinziCL , VeederMH , AthmannLM , ThereauTM , et al. Inhibition of fluorouracil‐induced stomatitis by oral cryotherapy. Journal of Clinical Oncology1991;9(3):449‐52. ">Mahood 1991</a>; <a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>), all at high risk of bias and analysing 444 participants, were combined in a meta‐analysis which showed that oral cryotherapy reduced the risk of developing oral mucositis (risk ratio (RR) 0.61, 95% confidence interval (CI) 0.52 to 0.72, P &lt; 0.00001) when compared to control (<a href="./references#CD011552-fig-0003" title="">Analysis 1.1</a>). There was no heterogeneity in this effect estimate (I<sup>2</sup> = 0%). This can be interpreted as a 39% (95% CI 28% to 48%) reduction in the risk of developing oral mucositis associated with oral cryotherapy. Or in other words, 4 people (95% CI 3 to 5 people) would need to receive oral cryotherapy in order to prevent one additional person from developing oral mucositis. </p> </section> <section id="CD011552-sec-0096"> <h6 class="title">High‐dose melphalan‐based treatment prior to stem cell transplantation</h6> <p>Five studies (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>; <a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>; <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>), all at high risk of bias and analysing 270 participants, were combined in a meta‐analysis. There is evidence to show that oral cryotherapy reduced the risk of developing oral mucositis (RR 0.59, 95% CI 0.35 to 1.01, P = 0.05) when compared to control (<a href="./references#CD011552-fig-0003" title="">Analysis 1.1</a>). Oral cryotherapy reduced the risk of developing oral mucositis by 41% although the uncertainty surrounding this effect estimate means that the 95% CI ranges from a 65% reduction to a 1% increase in risk. We would need to treat 3 people with oral cryotherapy to prevent one additional person from developing oral mucositis. The confidence interval ranges from 2 people needing to receive oral cryotherapy to prevent one additional person from developing oral mucositis, to 111 people needing to receive oral cryotherapy for one additional person to develop oral mucositis. There was considerable heterogeneity associated with this effect estimate (I<sup>2</sup> = 95%), although the reason/s for this inconsistency is/are not clear on investigation of the characteristics of the studies, in terms of the participants, settings, methods, and interventions. </p> </section> <section id="CD011552-sec-0097"> <h6 class="title">Methotrexate treatment post‐stem cell transplantation to prevent graft versus host disease </h6> <p>One study (<a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>), at high risk of bias and analysing 122 participants, showed that there is insufficient evidence to determine whether or not oral cryotherapy reduces the risk of developing oral mucositis (RR 0.98, 95% CI 0.90 to 1.07, P = 0.73) when compared to control (<a href="./references#CD011552-fig-0003" title="">Analysis 1.1</a>). </p> </section> <section id="CD011552-sec-0098"> <h6 class="title">Radiotherapy to the head and neck</h6> <p>One study (<a href="./references#CD011552-bbs2-0005" title="KakoeiS , GhassemiA , NakhaeiNR . Effect of cryotherapy on oral mucositis in patients with head and neck cancers receiving radiotherapy. International Journal of Radiation Research2013;11(2):117‐20. ">Kakoei 2013</a>), at high risk of bias and analysing 40 participants, showed that there is insufficient evidence to determine whether or not oral cryotherapy reduces the mean severity of oral mucositis 14 days after radiotherapy (mean difference (MD) ‐0.25, 95% CI ‐0.72 to 0.22, P = 0.29) when compared to control (Additional <a href="#CD011552-tbl-0003">Table 1</a>). </p> <div class="table" id="CD011552-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study data not included in analyses</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Description of data</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cryotherapy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Result</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Oral mucositis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kakoei 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>WHO 0 to 4 scale; physician‐judged rating used; day 14 data used due to highest control group mean (should be noted that on days 1 and 7 the cryotherapy group mean is higher but with no statistically significant difference) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 20</p> <p>mean 0.95 (SD 0.58)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 20</p> <p>mean 1.2 (SD 0.89)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MD ‐0.25 (95% CI ‐0.72 to 0.22); P = 0.29 (there is no evidence of a difference in mucositis severity) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Oral pain</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heydari 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 to 5 scale: 1 = never, 2 = 1 day of week, 3 = 2 to 3 days of week, 4 = most of week, 5 = 7 days of week </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 40</p> <p>mean 1.71 (SD 0.74)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 40</p> <p>mean 3.64 (SD 1.20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MD ‐1.93 (95% CI ‐2.37 to ‐1.49); P &lt; 0.00001 (cryotherapy statistically significantly reduced the duration of pain experience) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Normalcy of diet</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lilleby 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Days of TPN (we use the P value quoted in the study report)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 21</p> <p>median 2 (range 0 to 15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 19</p> <p>median 5.5 (range 0 to 21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P = 0.04 (cryotherapy statistically significantly reduced the number of days of TPN)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of days in hospital</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lilleby 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Days of hospitalisation (we use the P value quoted in the study report)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 21</p> <p>median 9 (range 0 to 22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 19</p> <p>median 14 (range 0 to 30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P = 0.11 (there is no evidence of a difference in the number of days of hospitalisation)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of days of treatment with opioid analgesics</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lilleby 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Days of IV narcotics (we use the P value quoted in the study report)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 21</p> <p>median 0 (range 0 to 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 19</p> <p>median 5.5 (range 0 to 13)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P = 0.0003 (cryotherapy statistically significantly reduced the number of days of IV narcotics) </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI = confidence interval; IV = intravenous; MD = mean difference; n = number of participants analysed; N/A = not applicable; SD = standard deviation; TPN = total parenteral nutrition </p> </div> </div> </section> </section> <section id="CD011552-sec-0099"> <h5 class="title">Oral mucositis (moderate to severe)</h5> <section id="CD011552-sec-0100"> <h6 class="title">Fluorouracil (5FU) treatment for solid cancers</h6> <p>The same five studies (<a href="./references#CD011552-bbs2-0002" title="CascinuS , FedeliA , FedeliSL , CatalanoG . Oral cooling (cryotherapy), an effective treatment for the prevention of 5‐fluorouracil‐induced stomatitis. European Journal of Cancer. Part B, Oral Oncology1994;30B(4):234‐6. ">Cascinu 1994</a>; <a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>; <a href="./references#CD011552-bbs2-0006" title="KatranciN , OvayoluN , OvayoluO , SevincA . Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy ‐ a randomized controlled trial. European Journal of Oncology Nursing2012;16(4):339‐44. ">Katranci 2012</a>; <a href="./references#CD011552-bbs2-0008" title="DoseAM , MahoodD , LoprinziCL , GaineyD , SorensenJM , TherneauT . A controlled trial of oral cryotherapy for preventing stomatitis in patients receiving 5‐fluorouracil (5FU) plus leucovorin (LV). A North Central Cancer Treatment Group and Mayo Clinic Study. Proceedings of the 26th Annual Meeting of the American Society of Clinical Oncology; 1990, May 20‐22; Washington DC, USA. 1990; Vol. 9:321, Abstract no: 1242. MahoodDJ , DoseAM , LoprinziCL , VeederMH , AthmannLM , ThereauTM , et al. Inhibition of fluorouracil‐induced stomatitis by oral cryotherapy. Journal of Clinical Oncology1991;9(3):449‐52. ">Mahood 1991</a>; <a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>), when combined, showed that oral cryotherapy reduced the risk of developing moderate to severe oral mucositis (RR 0.52, 95% CI 0.41 to 0.65, P &lt; 0.00001) when compared to control (<a href="./references#CD011552-fig-0004" title="">Analysis 1.2</a>). There was no heterogeneity (I<sup>2</sup> = 0%). Oral cryotherapy reduced the risk of developing moderate to severe oral mucositis by 48% (95% CI 35% to 59%). We would need to treat 4 people (95% CI 4 to 6 people) with oral cryotherapy in order to prevent one additional person from developing moderate to severe oral mucositis. </p> </section> <section id="CD011552-sec-0101"> <h6 class="title">High‐dose melphalan‐based treatment prior to stem cell transplantation</h6> <p>The same five studies (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>; <a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>; <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>), when combined, showed that there is evidence to show that oral cryotherapy reduced the risk of developing moderate to severe oral mucositis (RR 0.43, 95% CI 0.17 to 1.09, P = 0.07) when compared to control (<a href="./references#CD011552-fig-0004" title="">Analysis 1.2</a>). Oral cryotherapy reduced the risk of developing moderate to severe oral mucositis by 57% although the uncertainty surrounding this effect estimate means that the 95% CI ranges from a 83% reduction to a 9% increase in risk. We would need to treat 3 people with oral cryotherapy to prevent one additional person from developing moderate to severe oral mucositis. The confidence interval ranges from 2 people needing to receive oral cryotherapy to prevent one additional person from developing moderate to severe oral mucositis, to 17 people needing to receive oral cryotherapy for one additional person to develop moderate to severe oral mucositis. There was considerable heterogeneity associated with this effect estimate (I<sup>2</sup> = 92%), although the reason/s for this inconsistency is/are not clear on investigation of the characteristics of the studies, in terms of the participants, settings, methods, and interventions. </p> </section> <section id="CD011552-sec-0102"> <h6 class="title">Methotrexate treatment post‐stem cell transplantation to prevent graft versus host disease </h6> <p>The same study (<a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>) showed that there is insufficient evidence to determine whether or not oral cryotherapy reduces the risk of developing moderate to severe oral mucositis (RR 1.01, 95% CI 0.85 to 1.20, P = 0.93) when compared to control (<a href="./references#CD011552-fig-0004" title="">Analysis 1.2</a>). </p> </section> <section id="CD011552-sec-0103"> <h6 class="title">Radiotherapy to the head and neck</h6> <p>The study in this subgroup did not assess this outcome.</p> </section> </section> <section id="CD011552-sec-0104"> <h5 class="title">Oral mucositis (severe)</h5> <section id="CD011552-sec-0105"> <h6 class="title">Fluorouracil (5FU) treatment for solid cancers</h6> <p>The same five studies (<a href="./references#CD011552-bbs2-0002" title="CascinuS , FedeliA , FedeliSL , CatalanoG . Oral cooling (cryotherapy), an effective treatment for the prevention of 5‐fluorouracil‐induced stomatitis. European Journal of Cancer. Part B, Oral Oncology1994;30B(4):234‐6. ">Cascinu 1994</a>; <a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>; <a href="./references#CD011552-bbs2-0006" title="KatranciN , OvayoluN , OvayoluO , SevincA . Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy ‐ a randomized controlled trial. European Journal of Oncology Nursing2012;16(4):339‐44. ">Katranci 2012</a>; <a href="./references#CD011552-bbs2-0008" title="DoseAM , MahoodD , LoprinziCL , GaineyD , SorensenJM , TherneauT . A controlled trial of oral cryotherapy for preventing stomatitis in patients receiving 5‐fluorouracil (5FU) plus leucovorin (LV). A North Central Cancer Treatment Group and Mayo Clinic Study. Proceedings of the 26th Annual Meeting of the American Society of Clinical Oncology; 1990, May 20‐22; Washington DC, USA. 1990; Vol. 9:321, Abstract no: 1242. MahoodDJ , DoseAM , LoprinziCL , VeederMH , AthmannLM , ThereauTM , et al. Inhibition of fluorouracil‐induced stomatitis by oral cryotherapy. Journal of Clinical Oncology1991;9(3):449‐52. ">Mahood 1991</a>; <a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>), when combined, showed that oral cryotherapy reduced the risk of developing severe oral mucositis (RR 0.40, 95% CI 0.27 to 0.61, P &lt; 0.0001) when compared to control (<a href="./references#CD011552-fig-0005" title="">Analysis 1.3</a>). There was no heterogeneity (I<sup>2</sup> = 0%). Oral cryotherapy reduced the risk of developing severe oral mucositis by 60% (39% to 73%). We would need to treat 6 people (95% CI 5 to 9 people) with oral cryotherapy to prevent one additional person from developing severe oral mucositis. </p> </section> <section id="CD011552-sec-0106"> <h6 class="title">High‐dose melphalan‐based treatment prior to stem cell transplantation</h6> <p>The same five studies (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>; <a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>; <a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>), when combined, showed that oral cryotherapy reduced the risk of developing severe oral mucositis (RR 0.38, 95% CI 0.20 to 0.72, P = 0.003) when compared to control (<a href="./references#CD011552-fig-0005" title="">Analysis 1.3</a>). Oral cryotherapy reduced the risk of developing severe oral mucositis by 62% (95% CI 28% to 80%). We would need to treat 4 people (95% CI 3 to 9 people) with oral cryotherapy to prevent one additional person from developing severe oral mucositis. There was moderate amount of heterogeneity associated with this effect estimate (I<sup>2</sup> = 42%), although the reason/s for this inconsistency is/are not clear on investigation of the characteristics of the studies, in terms of the participants, settings, methods, and interventions. </p> </section> <section id="CD011552-sec-0107"> <h6 class="title">Methotrexate treatment post‐stem cell transplantation to prevent graft versus host disease </h6> <p>The same study (<a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>) showed that there is insufficient evidence to determine whether or not oral cryotherapy reduces the risk of developing moderate to severe oral mucositis (RR 0.88, 95% CI 0.61 to 1.25, P = 0.47) when compared to control (<a href="./references#CD011552-fig-0005" title="">Analysis 1.3</a>). </p> </section> <section id="CD011552-sec-0108"> <h6 class="title">Radiotherapy to the head and neck</h6> <p>The study in this subgroup did not assess this outcome.</p> </section> </section> <section id="CD011552-sec-0109"> <h5 class="title">Interruptions to cancer treatment</h5> <section id="CD011552-sec-0110"> <h6 class="title">Fluorouracil (5FU) treatment for solid cancers</h6> <p>One study (<a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>), at high risk of bias and analysing 80 participants, showed that oral cryotherapy reduced the risk of treatment interruption (RR 0.44, 95% CI 0.20 to 0.95, P = 0.04) when compared to control (<a href="./references#CD011552-fig-0006" title="">Analysis 1.4</a>). In other words, oral cryotherapy reduced the risk of treatment interruption by 56% (95% CI 5% to 80%). We would need to treat 5 people (95% 4 to 50 people) with oral cryotherapy in order to prevent one additional person from having a treatment interruption. The uncertainty, due to the single study with a small number of participants, surrounding this effect estimate is reflected by the wide range in the confidence interval. </p> <p>The same study showed that oral cryotherapy reduced the duration of treatment interruption by eight days (95% CI 9.26 to 6.74 days, P &lt; 0.00001) when compared to control (<a href="./references#CD011552-fig-0007" title="">Analysis 1.5</a>). </p> </section> <section id="CD011552-sec-0111"> <h6 class="title">High‐dose melphalan‐based treatment prior to stem cell transplantation</h6> <p>No studies in this subgroup assessed this outcome.</p> </section> <section id="CD011552-sec-0112"> <h6 class="title">Graft versus host disease prophylaxis</h6> <p>The study in this subgroup did not assess this outcome.</p> </section> <section id="CD011552-sec-0113"> <h6 class="title">Radiotherapy to the head and neck</h6> <p>The study in this subgroup did not assess this outcome.</p> </section> </section> <section id="CD011552-sec-0114"> <h5 class="title">Oral pain</h5> <section id="CD011552-sec-0115"> <h6 class="title">Fluorouracil (5FU) treatment for solid cancers</h6> <p>One study (<a href="./references#CD011552-bbs2-0004" title="HeydariA , SharifiH , SalekR . Effect of oral cryotherapy on combination chemotherapy‐induced oral mucositis: a randomized clinical trial. Middle East Journal of Cancer2012;3(2/3):55‐64. ">Heydari 2012</a>), at high risk of bias and analysing 80 participants, showed that oral cryotherapy reduced the duration of oral pain experience (MD ‐1.93, 95% CI ‐2.37 to ‐1.49, P &lt; 0.00001) when compared to control (Additional <a href="#CD011552-tbl-0003">Table 1</a>). The 1 to 5 scale used to measure this outcome makes it impossible to accurately interpret this result in any meaningful way. </p> </section> <section id="CD011552-sec-0116"> <h6 class="title">High‐dose melphalan‐based treatment prior to stem cell transplantation</h6> <p>Two studies (<a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>; <a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>), both at high risk of bias and analysing 85 participants, showed that oral cryotherapy reduced the intensity of oral pain (MD ‐1.50, 95% CI ‐2.11 to ‐0.89, P &lt; 0.00001) when compared to control (<a href="./references#CD011552-fig-0008" title="">Analysis 1.6</a>). There was a negligible amount of heterogeneity associated with this effect estimate (I<sup>2</sup> = 4%). This result represents a 70% reduction in oral pain but this figure may be misleading as there was only a 1.5 point reduction on a 0 to 10 scale. </p> </section> <section id="CD011552-sec-0117"> <h6 class="title">Graft versus host disease prophylaxis</h6> <p>The study in this subgroup did not assess this outcome.</p> </section> <section id="CD011552-sec-0118"> <h6 class="title">Radiotherapy to the head and neck</h6> <p>The study in this subgroup assessed oral pain but did not report details of the scale used, so we were unable to use the data. </p> </section> </section> <section id="CD011552-sec-0119"> <h5 class="title">Quality of life</h5> <section id="CD011552-sec-0120"> <h6 class="title">Fluorouracil (5FU) treatment for solid cancers</h6> <p>No studies in this subgroup assessed this outcome.</p> </section> <section id="CD011552-sec-0121"> <h6 class="title">High‐dose melphalan‐based treatment prior to stem cell transplantation</h6> <p>One study assessed this outcome but the data are currently unavailable as the study report and analysis have not yet been completed (<a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>). </p> </section> <section id="CD011552-sec-0122"> <h6 class="title">Graft versus host disease prophylaxis</h6> <p>The study in this subgroup did not assess this outcome.</p> </section> <section id="CD011552-sec-0123"> <h6 class="title">Radiotherapy to the head and neck</h6> <p>The study in this subgroup did not assess this outcome.</p> </section> </section> <section id="CD011552-sec-0124"> <h5 class="title">Normalcy of diet</h5> <section id="CD011552-sec-0125"> <h6 class="title">Fluorouracil (5FU) treatment for solid cancers</h6> <p>No studies in this subgroup assessed this outcome.</p> </section> <section id="CD011552-sec-0126"> <h6 class="title">High‐dose melphalan‐based treatment prior to stem cell transplantation</h6> <p>One study, at high risk of bias and analysing 78 participants (<a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>), showed that oral cryotherapy reduced the duration of total parenteral nutrition by 2.18 days (95% CI 0.03 to 4.33 days, P = 0.05) when compared to control (<a href="./references#CD011552-fig-0009" title="">Analysis 1.7</a>). </p> <p>A further study, at high risk of bias and analysing 40 participants (<a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>), reported that oral cryotherapy reduced the number of days of total parenteral nutrition (Additional <a href="#CD011552-tbl-0003">Table 1</a>). </p> </section> <section id="CD011552-sec-0127"> <h6 class="title">Graft versus host disease prophylaxis</h6> <p>The study in this subgroup did not assess this outcome.</p> </section> <section id="CD011552-sec-0128"> <h6 class="title">Radiotherapy to the head and neck</h6> <p>The study in this subgroup did not assess this outcome.</p> </section> </section> <section id="CD011552-sec-0129"> <h5 class="title">Adverse events</h5> <section id="CD011552-sec-0130"> <h6 class="title">Fluorouracil (5FU) treatment for solid cancers</h6> <p>One study reported that there were no adverse effects ("problems") (<a href="./references#CD011552-bbs2-0006" title="KatranciN , OvayoluN , OvayoluO , SevincA . Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy ‐ a randomized controlled trial. European Journal of Oncology Nursing2012;16(4):339‐44. ">Katranci 2012</a>), whilst the other four studies reported low rates of very minor adverse events (headache, chills, numbness/taste disturbance). </p> </section> <section id="CD011552-sec-0131"> <h6 class="title">High‐dose melphalan‐based treatment prior to stem cell transplantation</h6> <p>One study did not report adverse events (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>), whilst another informed us by email that there were "no serious adverse events" (<a href="./references#CD011552-bbs2-0013" title="ToroJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A randomized trial of oral cryotherapy, saline solution and Caphosol for the prevention of high‐dose melphalan‐induced oral mucositis followed by autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S138. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. A prospective, randomized clinical trial of cryotherapy vs. Supersaturated calcium phosphate rinses vs. Saline rinses for the prevention of oral mucositis in patients with multiple myeloma (MM) receiving high‐dose melphalan (HDM) and autotransplantation. Biology of Blood and Marrow Transplantation2014;20(2 Suppl):S204‐5. ToroJJ , SchneiderD , AlonzoR , HasanA , LeeS , GushikenF , et al. Influence of oral mucositis on the quality of life of patients treated with high‐dose melphalan and autologous hematopoietic stem cell transplantation. Supportive Care in Cancer2013;21(1 Suppl):S139. ">Toro 2013</a>). The remaining two studies reported only low rates of shooting pain from the teeth (<a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>), and coldness (<a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>). In the latter study, this stopped some participants from continuing the cryotherapy regimen, although this is not surprising as they were required to hold ice in their mouths continuously for a total of seven hours. </p> </section> <section id="CD011552-sec-0132"> <h6 class="title">Graft versus host disease prophylaxis</h6> <p>The study in this subgroup did not report on adverse events.</p> </section> <section id="CD011552-sec-0133"> <h6 class="title">Radiotherapy to the head and neck</h6> <p>The study in this subgroup did not report on adverse events. However, we assume that there were none because the participants only had to hold ice in their mouth for 5‐minute periods. </p> </section> </section> <section id="CD011552-sec-0134"> <h5 class="title">Number of days in hospital</h5> <section id="CD011552-sec-0135"> <h6 class="title">Fluorouracil (5FU) treatment for solid cancers</h6> <p>No studies in this subgroup assessed this outcome.</p> </section> <section id="CD011552-sec-0136"> <h6 class="title">High‐dose melphalan‐based treatment prior to stem cell transplantation</h6> <p>Two studies (<a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>; <a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>), both at high risk of bias and analysing 123 participants, were combined in a meta‐analysis with no heterogeneity (I<sup>2</sup> = 0%). There is insufficient evidence to show that oral cryotherapy reduces the duration of hospitalisation (MD ‐1.39 days, 95% CI ‐2.97 to 0.19 days, P = 0.09) when compared to control (<a href="./references#CD011552-fig-0010" title="">Analysis 1.8</a>). </p> <p>A further study, at high risk of bias and analysing 40 participants (<a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>), reported that there was insufficient evidence to show a reduction in the duration of hospitalisation (Additional <a href="#CD011552-tbl-0003">Table 1</a>). </p> </section> <section id="CD011552-sec-0137"> <h6 class="title">Graft versus host disease prophylaxis</h6> <p>The study in this subgroup did not assess this outcome.</p> </section> <section id="CD011552-sec-0138"> <h6 class="title">Radiotherapy to the head and neck</h6> <p>The study in this subgroup did not assess this outcome.</p> </section> </section> <section id="CD011552-sec-0139"> <h5 class="title">Number of days of treatment with opioid analgesics</h5> <section id="CD011552-sec-0140"> <h6 class="title">Fluorouracil (5FU) treatment for solid cancers</h6> <p>No studies in this subgroup assessed this outcome.</p> </section> <section id="CD011552-sec-0141"> <h6 class="title">High‐dose melphalan‐based treatment prior to stem cell transplantation</h6> <p>One study (<a href="./references#CD011552-bbs2-0012" title="SvanbergA , BirgegardG , OhrnK . Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy‐‐a randomized controlled trial. Supportive Care in Cancer2007; Vol. 15, issue 10:1155‐61. SvanbergA , OhrnK , BirgegårdG . Oral cryotherapy reduces mucositis and improves nutrition ‐ a randomised controlled trial. Journal of Clinical Nursing2010;19(15‐16):2146‐51. SvanbergA , ÖhrnK . Cryotherapy during chemotherapy ‐ could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation2004;33 Suppl 1:S292. ">Svanberg 2007</a>), at high risk of bias and analysing 78 participants, showed that there is insufficient evidence to determine whether or not oral cryotherapy reduces the duration of opioid use (MD ‐2.28 days, 95% CI ‐5.33 to 0.77 days, P = 0.14) when compared to control (<a href="./references#CD011552-fig-0011" title="">Analysis 1.9</a>). </p> <p>A further study (<a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>), at high risk of bias and analysing 40 participants, reported that oral cryotherapy reduced the duration of opioid use (Additional <a href="#CD011552-tbl-0003">Table 1</a>). </p> </section> <section id="CD011552-sec-0142"> <h6 class="title">Graft versus host disease prophylaxis</h6> <p>The study in this subgroup did not assess this outcome.</p> </section> <section id="CD011552-sec-0143"> <h6 class="title">Radiotherapy to the head and neck</h6> <p>The study in this subgroup did not assess this outcome.</p> </section> </section> <section id="CD011552-sec-0144"> <h5 class="title">Number of days unable to take medicine orally</h5> <section id="CD011552-sec-0145"> <h6 class="title">Fluorouracil (5FU) treatment for solid cancers</h6> <p>No studies in this subgroup assessed this outcome.</p> </section> <section id="CD011552-sec-0146"> <h6 class="title">High‐dose melphalan‐based treatment prior to stem cell transplantation</h6> <p>No studies in this subgroup assessed this outcome.</p> </section> <section id="CD011552-sec-0147"> <h6 class="title">Graft versus host disease prophylaxis</h6> <p>The study in this subgroup did not assess this outcome.</p> </section> <section id="CD011552-sec-0148"> <h6 class="title">Radiotherapy to the head and neck</h6> <p>The study in this subgroup did not assess this outcome.</p> </section> </section> </section> <section id="CD011552-sec-0149"> <h4 class="title">Comparison 2: Different oral cryotherapy regimens</h4> <p>One study (<a href="./references#CD011552-bbs2-0009" title="RockeLK , LoprinziCL , LeeJK , KunselmanSJ , IversonRK , FinckG , et al. A randomized clinical trial of two different durations or oral cryotherapy for prevention of 5‐fluorouracil‐related stomatitis. Cancer1993;72(7):2234‐8. ">Rocke 1993</a>), at high risk of bias and analysing 178 participants having treatment for solid cancer (fluorouracil and leucovorin), showed that there is insufficient evidence to determine whether or not the risk of developing oral mucositis is different when using 30 minutes or 60 minutes of oral cryotherapy (RR 0.89, 95% CI 0.62 to 1.29, P = 0.54) (<a href="./references#CD011552-fig-0012" title="">Analysis 2.1</a>). </p> <p>The results were similar for the risk of developing moderate to severe oral mucositis (RR 0.68, 95% CI 0.36 to 1.30, P = 0.25) (<a href="./references#CD011552-fig-0013" title="">Analysis 2.2</a>), and severe oral mucositis (RR 0.60, 95% CI 0.23 to 1.58, P = 0.30) (<a href="./references#CD011552-fig-0014" title="">Analysis 2.3</a>). </p> <p>The study in this comparison did not assess any other outcomes of this review.</p> </section> <section id="CD011552-sec-0150"> <h4 class="title">Comparison 3: Cryotherapy versus chlorhexidine</h4> <p>One study (<a href="./references#CD011552-bbs2-0011" title="SorensenJ , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double blind, placebo‐controlled randomized study of chlorhexidine prophylaxis for chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology : ASCO annual meeting proceedings2006;24(18S Part I):470. SorensenJB , SkovsgaardT , BorkE , DamstrupL , IngebergS . Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer2008; Vol. 112, issue 7:1600‐6. ">Sorensen 2008</a>), at high risk of bias and analysing 133 participants having treatment for solid cancer (fluorouracil and leucovorin), showed that there is insufficient evidence to determine whether or not the risk of developing oral mucositis is different when using oral cryotherapy or chlorhexidine rinse (RR 0.97, 95% CI 0.71 to 1.32, P = 0.84) (<a href="./references#CD011552-fig-0015" title="">Analysis 3.1</a>). </p> <p>The results were similar for the risk of developing moderate to severe oral mucositis (RR 0.89, 95% CI 0.51 to 1.56, P = 0.68) (<a href="./references#CD011552-fig-0016" title="">Analysis 3.2</a>), and severe oral mucositis (RR 0.86, 95% CI 0.34 to 2.18, P = 0.76) (<a href="./references#CD011552-fig-0017" title="">Analysis 3.3</a>). </p> <p>The study in this comparison did not assess any other outcomes of this review.</p> </section> <section id="CD011552-sec-0151"> <h4 class="title">Comparison 4: Cryotherapy versus low‐dose leucovorin versus high‐dose leucovorin</h4> <p>One study (<a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>), at high risk of bias and analysing 147 participants having treatment for solid (osteosarcoma) cancer (high‐dose methotrexate, vincristine and leucovorin), showed that oral cryotherapy reduced the risk of developing oral mucositis when compared to both low‐dose leucovorin rinse (RR 0.67, 95% CI 0.50 to 0.90, P = 0.008) and high‐dose leucovorin rinse (RR 0.65, 95% CI 0.47 to 0.90, P = 0.01) (<a href="./references#CD011552-fig-0018" title="">Analysis 4.1</a>). </p> <p>There was insufficient evidence to determine whether or not the risk of developing moderate to severe oral mucositis is different when using oral cryotherapy or low‐dose leucovorin rinse (RR 0.18, 95% CI 0.01 to 3.42, P = 0.25), or when using oral cryotherapy compared to high‐dose leucovorin rinse (not estimable ‐ no participants had developed moderate or severe oral mucositis by the fourth day after chemotherapy when the data were reported) (<a href="./references#CD011552-fig-0019" title="">Analysis 4.2</a>). </p> <p>There was insufficient evidence to determine whether or not the risk of developing severe oral mucositis is different when using oral cryotherapy compared to either low‐dose or high‐dose leucovorin rinse (<a href="./references#CD011552-fig-0020" title="">Analysis 4.3</a>). No participants had developed severe oral mucositis by the fourth day after chemotherapy when the data were reported. </p> <p>The study in this comparison did not assess any other outcomes of this review.</p> </section> <section id="CD011552-sec-0152"> <h4 class="title">Compliance</h4> <p>Two studies did not report on compliance (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0014" title="ZhangW , LiLS , LuYW , ZhenJC , ZhangXL . Intervention research on preventing oral mucositis after using high dose methotrexate chemotherapy in osteosarcoma by gargling with calcium folinic. Chinese Pharmaceutical Journal2011;46(14):1126‐8. ">Zhang 2011</a>). The remaining studies reported a high degree of compliance, with the large majority of participants managing to keep their mouths constantly cooled. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011552-sec-0153" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011552-sec-0153"></div> <section id="CD011552-sec-0154"> <h3 class="title" id="CD011552-sec-0154">Summary of main results</h3> <p>Fourteen randomised controlled trials (RCTs) met our eligibility criteria and were included in this review. We assessed the body of evidence for each comparison and outcome using GRADE methodology (<a href="./references#CD011552-bbs2-0042" title="GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490. ">GRADE 2004</a>). Most of the evidence we found relates to the comparison of oral cryotherapy versus a control group of standard care or no treatment in adult patients. We only present a 'Summary of findings' table where we were able to perform a meta‐analysis for the main outcomes, thus we produced two separate tables for: 1) evidence for participants receiving fluorouracil‐based (5FU) treatment for solid cancers (<a href="./full#CD011552-tbl-0001">summary of findings Table for the main comparison</a>); and 2) evidence for participants receiving high‐dose melphalan‐based cancer treatment prior to haematopoietic stem cell transplantation (HSCT) (<a href="./full#CD011552-tbl-0002">summary of findings Table 2</a>). </p> <p>Our main findings are as follows.</p> <section id="CD011552-sec-0155"> <h4 class="title">Adults receiving 5FU‐based treatment for solid cancers</h4> <p> <ul id="CD011552-list-0012"> <li> <p>Oral cryotherapy probably reduces oral mucositis of all severities (moderate quality evidence). </p> </li> <li> <p>There is some weak evidence that oral cryotherapy reduces both the incidence of treatment interruptions and the duration of treatment interruptions (very low quality evidence). </p> </li> <li> <p>There is some weak evidence that oral cryotherapy reduces the duration of pain experience (very low quality evidence). </p> </li> </ul> </p> </section> <section id="CD011552-sec-0156"> <h4 class="title">Adults receiving high‐dose melphalan prior to HSCT</h4> <p> <ul id="CD011552-list-0013"> <li> <p>Oral cryotherapy may reduce the incidence of both oral mucositis (any severity versus none) and moderate to severe oral mucositis (low quality evidence), and probably does reduce the incidence of severe oral mucositis (moderate quality evidence). </p> </li> <li> <p>Oral cryotherapy may lead to a small reduction in oral pain (low quality evidence).</p> </li> <li> <p>There is some weak evidence that oral cryotherapy reduces the duration of total parenteral nutrition (TPN) (very low quality evidence). </p> </li> <li> <p>There is insufficient evidence to determine whether or not oral cryotherapy reduces the number of days in hospital (low quality evidence). </p> </li> <li> <p>There is insufficient evidence to determine whether or not oral cryotherapy reduces the number of days of treatment with opioid analgesics (very low quality evidence). </p> </li> </ul> </p> <p>There is insufficient evidence to determine the effects of oral cryotherapy in: a) people receiving low‐dose methotrexate for preventing graft‐versus‐host disease (GVHD) after HSCT; and b) people receiving head and neck radiotherapy (both very low quality evidence). </p> <p>For the other comparisons included in this review, there was only very low quality evidence provided by single studies. In participants receiving 5FU‐based treatment for solid cancers, there is insufficient evidence to determine whether or not there is a difference between: a) 30 minutes and 60 minutes of oral cryotherapy; or b) oral cryotherapy and chlorhexidine rinse, for reducing the risk of developing any severity of oral mucositis. In participants receiving high‐dose methotrexate, vincristine and leucovorin for bone cancer (osteosarcoma), there is some weak evidence that oral cryotherapy reduces the risk of developing oral mucositis when compared to leucovorin rinses. </p> <p>Oral cryotherapy is safe, with low rates of very minor adverse effects, which ensures that compliance with this therapy is generally high. </p> </section> </section> <section id="CD011552-sec-0157"> <h3 class="title" id="CD011552-sec-0157">Overall completeness and applicability of evidence</h3> <p>We have found evidence which partially answers the review question of whether or not oral cryotherapy can prevent oral mucositis in cancer patients who are receiving treatment. We have enough evidence to answer this question for adults receiving 5FU‐based treatment for solid cancers in a satisfactory manner. However, for adults with haematological cancers receiving melphalan‐based cancer treatment prior to HSCT, the evidence is not complete and may be difficult to apply to different settings due to conflicting results amongst the individual studies. We would welcome more evidence in this group of patients and in a variety of settings. There is also very limited evidence on people receiving chemotherapy as GVHD prophylaxis, and also people receiving radiotherapy, whilst there is no RCT evidence on people receiving targeted therapy. The rationale behind the biological plausibility for using oral cryotherapy in cancer patients receiving chemotherapy has been explained in the literature. However, this is not the case for patients receiving radiotherapy to the head and neck or targeted therapy, which makes it difficult to determine the procedure (i.e. when and for how long to perform cryotherapy), yet it is still worth further investigation if there is a chance that this simple intervention can help these patients. </p> <p>There is no evidence on the effects of this intervention in children, perhaps because it may be considered unfeasible to expect children to hold ice in their mouths for long periods of time, due to the discomfort caused. However, as demonstrated in some of the studies included in this review, there are alternatives to holding crushed ice or ice chips or ice cubes in the mouth, such as the use of iced water/drinks or ice lollies/popsicles. It is also possible that ice chips or cubes may be a potential choking hazard in children. </p> <p>There is also a lack of evidence on the effects of oral cryotherapy in low‐income and lower‐middle‐income countries. </p> </section> <section id="CD011552-sec-0158"> <h3 class="title" id="CD011552-sec-0158">Quality of the evidence</h3> <p>We included 14 RCTs that analysed 1280 participants. The body of evidence that we identified on adults receiving 5FU‐based treatment for solid cancers allows a fairly robust conclusion to be made about the effects of oral cryotherapy for reducing the risk of oral mucositis in that group of patients. That is to say we can be quite confident in the results and we therefore assessed the evidence as being of moderate quality. We downgraded the rating of the evidence by one level due to the lack of blinding of participants, personnel and outcome assessors. Lack of blinding of participants and personnel in these studies is an unavoidable problem and does not necessarily reflect the 'quality' in terms of whether or not the studies were well conducted, although it does affect the risk of bias, which we must account for in our assessment of the quality of the body of evidence. Future studies may avoid the risk of detection bias by using a more objective measurement tool for the assessment of oral mucositis. However, this would affect our ability to combine the new studies in meta‐analyses with the current published studies that all use either the WHO or NCI‐CTC tools, which incorporate subjective elements. </p> <p>The body of evidence that we identified on adults receiving high‐dose melphalan‐based cancer treatment prior to HSCT does not allow for such robust conclusions for the outcomes 'any mucositis' and 'moderate to severe mucositis'. There were the same problems with risk of bias as discussed above, and also inconsistency in the results of the individual studies, and we therefore downgraded our rating of the quality of the body of evidence by two levels, resulting in low quality evidence. Although we would conclude that oral cryotherapy may be beneficial in this group of patients, the results were very uncertain, with wide confidence intervals, and even the possibility of a slight increase in the risk of developing any or moderate to severe mucositis. However, we did not downgrade for precision as the upper confidence limits did not include appreciable harm, and also because we do not consider it to be very low quality evidence. The evidence for oral cryotherapy reducing the risk of severe oral mucositis in this group of patients was more robust, resulting in moderate quality evidence. </p> <p>We did not downgrade either of the above bodies of evidence for indirectness resulting from the studies only being conducted on adults. However, there is some evidence that, with some diseases, children have more toxicity than adults who receive the same chemotherapy regimens (<a href="./references#CD011552-bbs2-0046" title="JuergensC , WestonC , LewisI , WhelanJ , PaulussenM , OberlinO , et al. Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO‐E.W.I.N.G. 99 clinical trial. Pediatric Blood &amp; Cancer2006;47(1):22‐9. ">Juergens 2006</a>). Therefore, it is possible that results in adults are not directly applicable to children, who may metabolise drugs differently and therefore experience different toxicity severity. </p> <p>There was insufficient evidence, of very low quality, on the effects of oral cryotherapy for reducing the risk of oral mucositis to allow any conclusions to be made for people receiving chemotherapy as GVHD prophylaxis, and also people receiving radiotherapy. This was downgraded for risk of bias, imprecision and indirectness, the latter because they were single study subgroups and were not replicated in any other settings. There was no evidence relating to children‐only. </p> <p>It was unfortunate that there was such limited evidence on the secondary outcomes of this review. These outcomes, and others, are likely to be important to patients and clinicians, and this serves to highlight the importance of core outcomes sets such as the one published by Bellm et al (<a href="./references#CD011552-bbs2-0034" title="BellmLA , CunninghamG , DurnellL , EilersJ , EpsteinJB , FlemingT , et al. Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board. Cancer Investigation2002;20(5‐6):793‐800. ">Bellm 2002</a>). We would urge future trialists to utilise such outcome sets in order to standardise what is measured and how it is measured, so as to maximise the usefulness of data produced by the randomisation of people, and thus reduce research waste. </p> </section> <section id="CD011552-sec-0159"> <h3 class="title" id="CD011552-sec-0159">Potential biases in the review process</h3> <p>We attempted to minimise biases in the review process but we cannot discount the fact that it is affected by other biases. For example, there were two studies that presented oral mucositis incidence data on multiple days rather than our preferred format of presenting a maximum score experienced per participant over the whole study period (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0006" title="KatranciN , OvayoluN , OvayoluO , SevincA . Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy ‐ a randomized controlled trial. European Journal of Oncology Nursing2012;16(4):339‐44. ">Katranci 2012</a>). Rather than lose important data, we decided to present the data from the day on which the incidence of grades higher than 0 was highest. We chose this method with the intention of equating to the maximum score experience, though we acknowledge this is not ideal and may not equate accurately enough. Another decision we made was to exclude studies where the participants received oral cryotherapy plus another intervention, even if the control group also received the other intervention. For example, one study that we excluded compared oral cryotherapy plus laser therapy versus laser therapy (<a href="./references#CD011552-bbs2-0018" title="dePaula EduardoF , BezinelliLM , daGraça LopesRM , Nascimento SobrinhoJJ , HamerschlakN , CorreaL . Efficacy of cryotherapy associated with laser therapy for decreasing severity of melphalan‐induced oral mucositis during hematological stem‐cell transplantation: a prospective clinical study. Hematological Oncology2014 [Epub ahead of print]. ">de Paula Eduardo 2014</a>). We could not exclude the possibility of interaction between the interventions and therefore we would not be confident in stating that any effect was due to the cryotherapy. However, in some of the studies, both groups received standard care, with the intervention group also receiving oral cryotherapy. We felt that this was a different situation because the standard care involved things like advice and education on mouth care, or mouth rinsing with saline, none of which would interact with the cryotherapy in a way that could bias the results. </p> </section> <section id="CD011552-sec-0160"> <h3 class="title" id="CD011552-sec-0160">Agreements and disagreements with other studies or reviews</h3> <p>A recent meta‐analysis conducted in China on oral cryotherapy for preventing oral mucositis in patients with haematological cancers undergoing HSCT (<a href="./references#CD011552-bbs2-0059" title="WangL , GuZ , ZhaiR , ZhaoS , LuoL , LiD , et al. Efficacy of oral cryotherapy on oral mucositis prevention in patients with hematological malignancies undergoing hematopoietic stem cell transplantation: a meta‐analysis of randomized controlled trials. PLoS One2015;10(5):e0128763. ">Wang 2015</a>), concluded that oral cryotherapy reduces the incidence of severe oral mucositis (risk ratio (RR) 0.52, 95% confidence interval 0.27 to 0.99). This was a smaller reduction than we calculated (RR 0.38, 95% CI 0.20 to 0.72), but they included one study that we excluded due to the possibility of confounding (<a href="./references#CD011552-bbs2-0018" title="dePaula EduardoF , BezinelliLM , daGraça LopesRM , Nascimento SobrinhoJJ , HamerschlakN , CorreaL . Efficacy of cryotherapy associated with laser therapy for decreasing severity of melphalan‐induced oral mucositis during hematological stem‐cell transplantation: a prospective clinical study. Hematological Oncology2014 [Epub ahead of print]. ">de Paula Eduardo 2014</a>), another study that we did not include in this subgroup due to treatment differences (<a href="./references#CD011552-bbs2-0003" title="GoriE , ArpinatiM , BonifaziF , ErricoA , MegaA , AlberaniF , et al. Cryotherapy in the prevention of oral mucositis in patients receiving low‐dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplantation2007; Vol. 39, issue 6:347‐52. ">Gori 2007</a>), and another study that we have been unable to obtain the data for, which is currently listed in <a href="./references#CD011552-sec-0185" title="">Characteristics of studies awaiting classification</a> (<a href="./references#CD011552-bbs2-0027" title="LuY , ZhuX , DepeiW . Oral cryotherapy for the prevention of mucositis following myeloablative conditioning and hematopoietic stem cell transplantation. Blood2013;122(21):5466. ">Lu 2013</a>). We included two studies that the Chinese authors did not include, for which we managed to obtain data through correspondence with the study authors (<a href="./references#CD011552-bbs2-0001" title="AskarifarM , LakdizajiS , RamziM , RahmaniA , JabbarzadehF . The effect of oral cryotherapy on chemotherapy‐induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: a clinical trial. Iranian Red Crescent Medical Journal2015 [Epub ahead of print]. ">Askarifar 2015</a>; <a href="./references#CD011552-bbs2-0010" title="SalvadorP , AzusanoC , WangL , HowellD . A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management2012;44(1):64‐73. ">Salvador 2012</a>). The Chinese authors were also in agreement with our results on 'duration of opioid use' and 'days of TPN', although they included data from <a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a>, which reported medians and ranges for some of our outcomes, and it was not clear what methods they used to include this study in the meta‐analyses. The inclusion of <a href="./references#CD011552-bbs2-0007" title="LillebyK , GarciaP , GooleyT , McDonnnellP , TaberR , HolmbergL , et al. A prospective, randomized study of cryotherapy during administration of high‐dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation2006;37(11):1031‐5. ">Lilleby 2006</a> data in their meta‐analysis for the outcome 'duration of hospitalisation' resulted in a significant result in favour of oral cryotherapy, in contrast to our result which did not achieve significance. </p> <p>Our results strongly support the conclusions of another systematic review of oral cryotherapy that was carried out by the Mucositis Study Group (MSG) of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO), and that is not limited to RCTs (<a href="./references#CD011552-bbs2-0052" title="PetersonDE , OhrnK , BowenJ , FliednerM , LeesJ , LoprinziC , et al. Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Supportive Care in Cancer2013;21(1):327‐32. ">Peterson 2013</a>). This review feeds into the 'MASCC/ISOO Clinical Practice Guidelines for the Management of Mucositis Secondary to Cancer Therapy (<a href="./references#CD011552-bbs2-0049" title="LallaRV , BowenJ , BaraschA , EltingL , EpsteinJ , KeefeDM , et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer2014;120(10):1453‐61. ">Lalla 2014</a>). Specifically, the guidance from this group is currently as follows. </p> <p> <ul id="CD011552-list-0014"> <li> <p>Recommendations in favour of an intervention (i.e. strong evidence supporting effectiveness): The panel <i>recommends</i> that 30 minutes of oral cryotherapy be used to <i>prevent</i> oral mucositis in patients receiving bolus 5FU chemotherapy (level II evidence). </p> </li> <li> <p>Suggestions in favour of an intervention (i.e. weaker evidence supporting effectiveness): The panel <i>suggests</i> that oral cryotherapy be used to <i>prevent</i> oral mucositis in patients receiving high‐dose melphalan, with or without total body irradiation, as conditioning for HSCT (level III evidence). </p> </li> </ul> </p> <p>This guidance is perhaps further strengthened by our Cochrane systematic review, as we have included new data/evidence not included in the MASCC/ISOO review or guidelines, yet the conclusions remain the same. It could even be argued that, due to the new data included in our two subgroups of patients matching those above, the level of evidence would now be level I for patients receiving bolus 5FU chemotherapy, and level I or II for patients receiving high‐dose melphalan, with or without total body irradiation, as conditioning for HSCT. Level I evidence is "evidence obtained from meta‐analysis of multiple, well‐designed, controlled studies; randomized trials with low false‐positive and false‐negative errors (high power)" (<a href="./references#CD011552-bbs2-0049" title="LallaRV , BowenJ , BaraschA , EltingL , EpsteinJ , KeefeDM , et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer2014;120(10):1453‐61. ">Lalla 2014</a>). There are now five RCTs in our 5FU subgroup with sufficient power to give a clear and fairly precise result. Our melphalan subgroup also now has five RCTs, but with fewer participants, giving a less precise result. However, the evidence for prevention of severe oral mucositis in this subgroup is fairly robust. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011552-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011552-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/full#CD011552-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011552-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD011552-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/full#CD011552-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011552-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Cryotherapy versus control, Outcome 1 Oral mucositis (any)." data-id="CD011552-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Cryotherapy versus control, Outcome 1 Oral mucositis (any).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011552-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Cryotherapy versus control, Outcome 2 Oral mucositis (moderate + severe)." data-id="CD011552-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Cryotherapy versus control, Outcome 2 Oral mucositis (moderate + severe).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011552-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Cryotherapy versus control, Outcome 3 Oral mucositis (severe)." data-id="CD011552-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Cryotherapy versus control, Outcome 3 Oral mucositis (severe).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011552-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Cryotherapy versus control, Outcome 4 Interruptions to cancer treatment." data-id="CD011552-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Cryotherapy versus control, Outcome 4 Interruptions to cancer treatment.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011552-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Cryotherapy versus control, Outcome 5 Interruptions to cancer treatment (days of interruption)." data-id="CD011552-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Cryotherapy versus control, Outcome 5 Interruptions to cancer treatment (days of interruption). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011552-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Cryotherapy versus control, Outcome 6 Oral pain (0 to 10 scale)." data-id="CD011552-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Cryotherapy versus control, Outcome 6 Oral pain (0 to 10 scale).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011552-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Cryotherapy versus control, Outcome 7 Normalcy of diet (days of total parenteral nutrition)." data-id="CD011552-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Cryotherapy versus control, Outcome 7 Normalcy of diet (days of total parenteral nutrition). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011552-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Cryotherapy versus control, Outcome 8 Duration of hospitalisation (days)." data-id="CD011552-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Cryotherapy versus control, Outcome 8 Duration of hospitalisation (days).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011552-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Cryotherapy versus control, Outcome 9 Duration of opioid use (days)." data-id="CD011552-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Cryotherapy versus control, Outcome 9 Duration of opioid use (days).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011552-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Different oral cryotherapy regimens, Outcome 1 Oral mucositis (any)." data-id="CD011552-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Different oral cryotherapy regimens, Outcome 1 Oral mucositis (any).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011552-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Different oral cryotherapy regimens, Outcome 2 Oral mucositis (moderate + severe)." data-id="CD011552-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Different oral cryotherapy regimens, Outcome 2 Oral mucositis (moderate + severe). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011552-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Different oral cryotherapy regimens, Outcome 3 Oral mucositis (severe)." data-id="CD011552-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Different oral cryotherapy regimens, Outcome 3 Oral mucositis (severe).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011552-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Cryotherapy versus chlorhexidine, Outcome 1 Oral mucositis (any)." data-id="CD011552-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Cryotherapy versus chlorhexidine, Outcome 1 Oral mucositis (any).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011552-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Cryotherapy versus chlorhexidine, Outcome 2 Oral mucositis (moderate + severe)." data-id="CD011552-fig-0016" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Cryotherapy versus chlorhexidine, Outcome 2 Oral mucositis (moderate + severe). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011552-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Cryotherapy versus chlorhexidine, Outcome 3 Oral mucositis (severe)." data-id="CD011552-fig-0017" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Cryotherapy versus chlorhexidine, Outcome 3 Oral mucositis (severe).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011552-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Cryotherapy versus leucovorin, Outcome 1 Oral mucositis (any)." data-id="CD011552-fig-0018" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Cryotherapy versus leucovorin, Outcome 1 Oral mucositis (any).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011552-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Cryotherapy versus leucovorin, Outcome 2 Oral mucositis (moderate + severe)." data-id="CD011552-fig-0019" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Cryotherapy versus leucovorin, Outcome 2 Oral mucositis (moderate + severe).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011552-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/urn:x-wiley:14651858:media:CD011552:CD011552-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_t/tCD011552-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Cryotherapy versus leucovorin, Outcome 3 Oral mucositis (severe)." data-id="CD011552-fig-0020" src="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Cryotherapy versus leucovorin, Outcome 3 Oral mucositis (severe).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/media/CDSR/CD011552/image_n/nCD011552-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011552-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Cryotherapy versus control for preventing oral mucositis in adults receiving fluorouracil‐based treatment for solid cancers</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Cryotherapy versus control for preventing oral mucositis in adults receiving fluorouracil‐based treatment for solid cancers</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults** with solid cancers receiving fluorouracil‐based cancer treatment<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> cryotherapy<br/> <b>Comparison:</b> control (no treatment or routine care) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with cryotherapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral mucositis (any)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>728 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>444 per 1000<br/> (379 to 524) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.61<br/> (0.52 to 0.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>444<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral cryotherapy reduced the risk of developing oral mucositis by 39% (95% CI 28% to 48%). We would need to treat 4 people (95% CI 3 to 5 people) with oral cryotherapy to prevent 1 additional person from developing oral mucositis </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral mucositis (moderate + severe)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>530 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>276 per 1000<br/> (217 to 344) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.52<br/> (0.41 to 0.65) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>444<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral cryotherapy reduced the risk of developing moderate to severe oral mucositis by 48% (95% CI 35% to 59%). We would need to treat 4 people (95% CI 4 to 6 people) with oral cryotherapy to prevent 1 additional person from developing moderate to severe oral mucositis </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral mucositis (severe)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>300 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>120 per 1000<br/> (81 to 183) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.40<br/> (0.27 to 0.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>444<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral cryotherapy reduced the risk of severe oral mucositis by 60% (95% CI 39% to 73%). We would need to treat 6 people (95% CI 5 to 9 people) with oral cryotherapy to prevent 1 additional person from developing severe oral mucositis </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interruptions to cancer treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>400 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>176 per 1000<br/> (80 to 380) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.44<br/> (0.20 to 0.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral cryotherapy reduced the risk of treatment interruption by 56% (95% CI 5% to 80%). We would need to treat 5 people (95% CI 4 to 50 people) with oral cryotherapy to prevent 1 additional person from having a treatment interruption </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral pain (1 to 5 scale: 1 = never, 2 = 1 day of week, 3 = 2 to 3 days of week, 4 = most of week, 5 = 7 days of week) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean oral pain (1 to 5 scale) was 3.64</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean oral pain (1 to 5 scale) in the cryotherapy group was 1.93 lower (2.37 to 1.49 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The duration of oral pain experienced was less in the oral cryotherapy group (Additional <a href="#CD011552-tbl-0003">Table 1</a>) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Normalcy of diet (days of total parenteral nutrition)</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Duration of hospitalisation (days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> All 5 studies at high risk of performance and detection bias </p> <p><sup>2</sup> Single study at high risk of performance and detection bias </p> <p><sup>3</sup> Low sample size and wide confidence interval </p> <p><sup>4</sup> Indirect due to single study in 1 setting (in terms of country, healthcare system, and participants potentially differing from other countries) </p> <p>** There were no studies conducted on children</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Cryotherapy versus control for preventing oral mucositis in adults receiving fluorouracil‐based treatment for solid cancers</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/full#CD011552-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011552-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Cryotherapy versus control for preventing oral mucositis in adults receiving high‐dose melphalan‐based treatment prior to haematopoietic stem cell transplantation for haematological cancers</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Cryotherapy versus control for preventing oral mucositis in adults receiving high‐dose melphalan‐based treatment prior to haematopoietic stem cell transplantation for haematological cancers</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults** with haematological cancers receiving high‐dose melphalan‐based treatment prior to haematopoietic stem cell transplantation<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> cryotherapy<br/> <b>Comparison:</b> control (no treatment or routine care) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with cryotherapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral mucositis (any)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>824 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>486 per 1000<br/> (289 to 833) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.59<br/> (0.35 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>270<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral cryotherapy appears to reduce the risk of developing oral mucositis. However, there is great uncertainty about our estimate, and there is an extremely small chance of a 1% increase in the risk of developing oral mucositis compared to control. The point estimate suggests a 41% reduction in the risk of developing oral mucositis, with the confidence interval ranging from a 65% reduction to a 1% increase in risk. We would need to treat 3 people with oral cryotherapy to prevent 1 additional person from developing oral mucositis, with the confidence interval ranging from 2 people (to prevent 1 additional oral mucositis case) to 111 people to cause 1 additional person to develop oral mucositis </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral mucositis (moderate + severe)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>679 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>292 per 1000<br/> (115 to 741) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.43<br/> (0.17 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>270<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral cryotherapy appears to reduce the risk of developing moderate to severe oral mucositis. However, there is great uncertainty about our estimate, and there is a very small chance of a 9% increase in the risk of developing moderate to severe oral mucositis compared to control. The point estimate suggests a 57% reduction in the risk of developing moderate to severe oral mucositis, with the confidence interval ranging from an 83% reduction to a 9% increase in risk. We would need to treat 3 people with oral cryotherapy to prevent 1 additional person from developing moderate to severe oral mucositis, with the confidence interval ranging from 2 people (to prevent 1 additional moderate to severe oral mucositis case) to 17 people to cause 1 additional person to develop moderate to severe oral mucositis </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral mucositis (severe)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>427 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>162 per 1000<br/> (85 to 308) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.38<br/> (0.20 to 0.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>270<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral cryotherapy reduced the risk of developing severe oral mucositis by 62% (95% CI 28% to 80%). We would need to treat 4 people (95% CI 3 to 9 people) with oral cryotherapy to prevent 1 additional person from developing severe oral mucositis </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interruptions to cancer treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral pain on a 0 (no pain) to 10 (maximum pain) scale</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The weighted mean oral pain (0 to 10 scale) was 2.13</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean oral pain (0 to 10 scale) in the cryotherapy group was 1.5 lower (2.11 to 0.89 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral cryotherapy reduced oral pain by 70% although the clinical importance of a 1.5 point‐reduction on a 0 to 10 scale is questionable </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>1 study assessed this outcome but the data are currently unavailable as the study report and analysis have not yet been completed </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Normalcy of diet (days of total parenteral nutrition ‐ TPN)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of days of TPN was 7</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of days of TPN in the intervention group was 2.18 days fewer (4.33 to 0.03 fewer) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>5 6 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral cryotherapy reduced the duration of TPN by 2.18 days. There was some additional very low quality evidence, from a single small study at high risk of bias, reporting only median, range and P value, that oral cryotherapy reduced the number of days of TPN (Additional <a href="#CD011552-tbl-0003">Table 1</a>) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Duration of hospitalisation (days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of hospitalisation (days) was 0</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of hospitalisation (days) in the intervention group was 1.39 undefined fewer (2.97 fewer to 0.19 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>123<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There is insufficient evidence to show that oral cryotherapy reduces the duration of hospitalisation. This is supported by additional very low quality evidence, from a single small study at high risk of bias, reporting only median, range and P value, that there is insufficient evidence to show a reduction in this outcome (Additional <a href="#CD011552-tbl-0003">Table 1</a>) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>TPN:</b> total parenteral nutrition </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> All 5 studies at risk of performance and detection bias, with 1 study at added risk of attrition bias </p> <p><sup>2</sup> The I<sup>2</sup> value indicates that a considerable amount (&gt; 90%) of the variability in effect estimates is due to heterogeneity rather than chance </p> <p><sup>3</sup> Both studies at high risk of performance and detection bias </p> <p><sup>4</sup> Low sample size from 2 small studies </p> <p><sup>5</sup> Single study at high risk of performance and detection bias </p> <p><sup>6</sup> Low sample size and wide confidence interval </p> <p><sup>7</sup> Indirect due to single study in 1 setting (in terms of country, healthcare system, and participants potentially differing from other countries) </p> <p>** There were no studies conducted on children</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Cryotherapy versus control for preventing oral mucositis in adults receiving high‐dose melphalan‐based treatment prior to haematopoietic stem cell transplantation for haematological cancers</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/full#CD011552-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011552-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study data not included in analyses</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Description of data</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cryotherapy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Result</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Oral mucositis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kakoei 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>WHO 0 to 4 scale; physician‐judged rating used; day 14 data used due to highest control group mean (should be noted that on days 1 and 7 the cryotherapy group mean is higher but with no statistically significant difference) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 20</p> <p>mean 0.95 (SD 0.58)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 20</p> <p>mean 1.2 (SD 0.89)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MD ‐0.25 (95% CI ‐0.72 to 0.22); P = 0.29 (there is no evidence of a difference in mucositis severity) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Oral pain</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heydari 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 to 5 scale: 1 = never, 2 = 1 day of week, 3 = 2 to 3 days of week, 4 = most of week, 5 = 7 days of week </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 40</p> <p>mean 1.71 (SD 0.74)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 40</p> <p>mean 3.64 (SD 1.20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MD ‐1.93 (95% CI ‐2.37 to ‐1.49); P &lt; 0.00001 (cryotherapy statistically significantly reduced the duration of pain experience) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Normalcy of diet</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lilleby 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Days of TPN (we use the P value quoted in the study report)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 21</p> <p>median 2 (range 0 to 15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 19</p> <p>median 5.5 (range 0 to 21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P = 0.04 (cryotherapy statistically significantly reduced the number of days of TPN)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of days in hospital</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lilleby 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Days of hospitalisation (we use the P value quoted in the study report)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 21</p> <p>median 9 (range 0 to 22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 19</p> <p>median 14 (range 0 to 30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P = 0.11 (there is no evidence of a difference in the number of days of hospitalisation)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of days of treatment with opioid analgesics</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lilleby 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Days of IV narcotics (we use the P value quoted in the study report)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 21</p> <p>median 0 (range 0 to 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 19</p> <p>median 5.5 (range 0 to 13)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P = 0.0003 (cryotherapy statistically significantly reduced the number of days of IV narcotics) </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>CI = confidence interval; IV = intravenous; MD = mean difference; n = number of participants analysed; N/A = not applicable; SD = standard deviation; TPN = total parenteral nutrition </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study data not included in analyses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/full#CD011552-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011552-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Cryotherapy versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Oral mucositis (any) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Fluorouracil (5FU) treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>444</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.52, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 High‐dose melphalan treatment prior to stem cell transplantation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.35, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Methotrexate treatment post‐stem cell transplantation to prevent GVHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.90, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Oral mucositis (moderate + severe) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Fluorouracil (5FU) treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>444</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.41, 0.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 High‐dose melphalan treatment prior to stem cell transplantation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.17, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Methotrexate treatment post‐stem cell transplantation to prevent GVHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.85, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Oral mucositis (severe) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Fluorouracil (5FU) treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>444</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.27, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 High‐dose melphalan treatment prior to stem cell transplantation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.20, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Methotrexate treatment post‐stem cell transplantation to prevent GVHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.61, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Interruptions to cancer treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.20, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Interruptions to cancer treatment (days of interruption) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.0 [‐9.26, ‐6.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Oral pain (0 to 10 scale) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.50 [‐2.11, ‐0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Normalcy of diet (days of total parenteral nutrition) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.18 [‐4.33, ‐0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Duration of hospitalisation (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.39 [‐2.97, 0.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Duration of opioid use (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.28 [‐5.33, 0.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Cryotherapy versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011552-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Different oral cryotherapy regimens</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Oral mucositis (any) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.62, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Oral mucositis (moderate + severe) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.36, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Oral mucositis (severe) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.6 [0.23, 1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Different oral cryotherapy regimens</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011552-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Cryotherapy versus chlorhexidine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Oral mucositis (any) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.71, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Oral mucositis (moderate + severe) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.51, 1.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Oral mucositis (severe) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.34, 2.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Cryotherapy versus chlorhexidine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011552-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Cryotherapy versus leucovorin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Oral mucositis (any) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Low‐dose leucovorin (3 mg daily)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.50, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 High‐dose leucovorin (200 mg daily)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.47, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Oral mucositis (moderate + severe) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Low‐dose leucovorin (3 mg daily)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.01, 3.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 High‐dose leucovorin (200 mg daily)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Oral mucositis (severe) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Low‐dose leucovorin (3 mg daily)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 High‐dose leucovorin (200 mg daily)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Cryotherapy versus leucovorin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011552.pub2/references#CD011552-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011552.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011552-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011552-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011552-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="hi#CD011552-note-0014">हिंदी</a> </li> <li class="section-language"> <a class="" href="hr#CD011552-note-0003">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD011552-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="th#CD011552-note-0004">ภาษาไทย</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011552\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011552\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011552\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011552\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011552\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011552\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011552\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011552\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011552\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011552\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011552\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011552\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011552\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011552\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011552\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011552\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011552\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011552\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=urvLIhM4&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011552.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011552.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011552.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011552.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011552.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724744283"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011552.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724744286"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011552.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e6a4839151c00',t:'MTc0MDcyNDc0NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 